US4203802A
(en)
*
|
1971-05-14 |
1980-05-20 |
Syva Company |
Inhibitable enzyme amplification assay
|
US3875011A
(en)
*
|
1972-11-06 |
1975-04-01 |
Syva Co |
Enzyme immunoassays with glucose-6-phosphate dehydrogenase
|
US3904367A
(en)
*
|
1973-08-15 |
1975-09-09 |
Gen Electric |
Contrast enhancement for immunological film detection
|
US4039652A
(en)
*
|
1973-10-11 |
1977-08-02 |
Miles Laboratories, Inc. |
Column method of immunoassay employing an immobilized binding partner
|
US3951748A
(en)
*
|
1974-11-11 |
1976-04-20 |
Medical Products, Inc. |
Sensitized matrix for detection of disease
|
SE388694B
(sv)
*
|
1975-01-27 |
1976-10-11 |
Kabi Ab |
Sett att pavisa ett antigen exv i prov av kroppvetskor, med utnyttjande av till porost berarmaterial bundna eller adsorberande antikroppar
|
NL7501215A
(nl)
*
|
1975-02-01 |
1976-08-03 |
Akzo Nv |
Methode voor het aantonen en bepalen van een antigeen of antilichaam.
|
IN142734B
(fr)
*
|
1975-04-28 |
1977-08-20 |
Miles Lab |
|
USRE32696E
(en)
*
|
1975-09-04 |
1988-06-14 |
Akzona Incorporated |
Enzymatic immunological method for determination of antigens and antibodies
|
US4016043A
(en)
*
|
1975-09-04 |
1977-04-05 |
Akzona Incorporated |
Enzymatic immunological method for the determination of antigens and antibodies
|
US4642285A
(en)
*
|
1975-09-29 |
1987-02-10 |
Diamedix Corporation |
Sandwich EIA for antigen
|
SE7610683L
(sv)
*
|
1975-09-29 |
1977-06-10 |
Cordis Corp |
Metod for bestemning av nervaron av ett antigen associerat med hepatit
|
US4474878A
(en)
*
|
1975-09-29 |
1984-10-02 |
Cordis Laboratories, Inc. |
Sandwich EIA for antigen associated with hepatitis
|
US4116776A
(en)
*
|
1976-04-19 |
1978-09-26 |
International Radioimmune Systems, Inc. |
Diagnostic blood test and kit for detecting human chorionic gonadotropin
|
GB1572220A
(en)
*
|
1976-10-07 |
1980-07-30 |
Mochida Pharm Co Ltd |
Immunochemical process of measuring physiologically active substances
|
GB1549069A
(en)
*
|
1976-12-10 |
1979-08-01 |
Erba Farmitalia |
Enzyme linked immunoassay
|
JPS5399319A
(en)
*
|
1977-02-09 |
1978-08-30 |
Hidematsu Hirai |
Novel qualitative and quantitative detecting method and detecting body for antgenic substance
|
IT1153999B
(it)
*
|
1977-03-15 |
1987-01-21 |
Snam Progetti |
Composizione atta alla determinazione della triiodotironina e metodo diagnostico impiegante la stessa
|
IL51668A
(en)
*
|
1977-03-16 |
1981-12-31 |
Israel State |
Analytical method for the quantitative determination of immunogens and antibodies and a kit therefor
|
CA1108516A
(fr)
*
|
1977-11-21 |
1981-09-08 |
Stanley E. Charm |
Methode pour detecter les traces d'antibiotiques
|
US4275149A
(en)
*
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
NL7804144A
(nl)
*
|
1978-04-18 |
1979-10-22 |
Akzo Nv |
Inrichting voor clorimetrische bepalingen.
|
NZ190452A
(en)
*
|
1978-05-19 |
1981-04-24 |
Becton Dickinson Co |
Solid phase assay receptor contacted with analyte and then with labeled analyte
|
JPS54170918U
(fr)
*
|
1978-05-23 |
1979-12-03 |
|
|
US4273756A
(en)
*
|
1978-07-28 |
1981-06-16 |
Abbott Laboratories |
Immunoassay for class specific antibodies
|
US4292296A
(en)
*
|
1978-09-12 |
1981-09-29 |
Baxter Travenol Laboratories, Inc. |
Diagnostic method
|
US4240751A
(en)
*
|
1978-11-09 |
1980-12-23 |
Akzona Incorporated |
Method and apparatus for specific binding substances
|
US4318707A
(en)
*
|
1978-11-24 |
1982-03-09 |
Syva Company |
Macromolecular fluorescent quencher particle in specific receptor assays
|
US4374925A
(en)
*
|
1978-11-24 |
1983-02-22 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
JPS55116258A
(en)
*
|
1979-03-01 |
1980-09-06 |
Fuji Photo Film Co Ltd |
Microimmunoassay method
|
JPS55116259A
(en)
*
|
1979-03-01 |
1980-09-06 |
Fuji Photo Film Co Ltd |
Microimmunoassay method
|
US4269938A
(en)
*
|
1979-03-08 |
1981-05-26 |
Eastman Kodak Company |
Assay of peroxidatively active materials
|
US4289748A
(en)
*
|
1979-05-31 |
1981-09-15 |
United States Of America |
Ultrasensitive enzymatic radioimmunoassay method
|
US4446231A
(en)
*
|
1979-10-03 |
1984-05-01 |
Self Colin H |
Immunoassay using an amplified cyclic detection system
|
GB2059421A
(en)
*
|
1979-10-03 |
1981-04-23 |
Self C H |
Assay method and reagents therefor
|
US4347312A
(en)
*
|
1980-03-20 |
1982-08-31 |
Research Triangle Institute |
Detection of antibiotics in milk
|
JPS56143955A
(en)
*
|
1980-04-10 |
1981-11-10 |
Fujirebio Inc |
Method for diagnosis of initial infection of syphilis
|
AU543007B2
(en)
*
|
1980-04-15 |
1985-03-28 |
Technicon Instruments Corportion |
Agglutination immunoassay
|
DE3016575A1
(de)
*
|
1980-04-30 |
1981-11-05 |
Merck Patent Gmbh, 6100 Darmstadt |
Verfahren zur immunologischen bestimmung von enzymen, mittel zur durchfuehrung des verfahrens und seine verwandung
|
EP0146654A3
(fr)
*
|
1980-06-20 |
1986-08-20 |
Unilever Plc |
Procédé et dispositif pour la réalisation d'essais à liaison spécifique
|
US6406920B1
(en)
|
1980-06-20 |
2002-06-18 |
Inverness Medical Switzerland Gmbh |
Processes and apparatus for carrying out specific binding assays
|
NL185309C
(nl)
|
1980-07-28 |
1990-03-01 |
Akzo Nv |
Methode voor het bepalen van antigenen met behulp van twee of meer monoklonale antilichamen alsmede immuunreagens.
|
US4376110A
(en)
*
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
US4486530A
(en)
*
|
1980-08-04 |
1984-12-04 |
Hybritech Incorporated |
Immunometric assays using monoclonal antibodies
|
US4323647A
(en)
*
|
1980-10-15 |
1982-04-06 |
University Of Miami |
Steric hindrance enzyme immunoassay
|
NZ199286A
(en)
*
|
1980-12-22 |
1986-05-09 |
Commw Serum Lab Commission |
A method of detecting antibodies or an antigenic or haptenic substance in a sample
|
US4517288A
(en)
*
|
1981-01-23 |
1985-05-14 |
American Hospital Supply Corp. |
Solid phase system for ligand assay
|
US4425438A
(en)
*
|
1981-03-13 |
1984-01-10 |
Bauman David S |
Assay method and device
|
GB2095258B
(en)
*
|
1981-03-19 |
1984-09-05 |
Janssen Pharmaceutica Nv |
A bright field light microscopic method of localizing tissue antigens
|
US4592995A
(en)
*
|
1981-03-30 |
1986-06-03 |
Dainippon Pharmaceutical Co., Ltd. |
Reagent for streptococcal anti-esterase assay
|
US4604365A
(en)
*
|
1981-06-02 |
1986-08-05 |
Electro-Nucleonics, Inc. |
Immunoprecipitation assay
|
JPS57193643U
(fr)
*
|
1981-06-03 |
1982-12-08 |
|
|
US4447528A
(en)
*
|
1981-08-10 |
1984-05-08 |
Corning Glass Works |
Detecting intrinsic factor blocking site antibody
|
EP0091911A4
(fr)
*
|
1981-08-31 |
1984-04-06 |
Icl Scient |
Detection immunohistochimique a l'oxydase de glucose d'anticorps anti-nucleaires.
|
US4452886A
(en)
*
|
1981-09-21 |
1984-06-05 |
Henry Robert P |
Novel photon absorbing or emitting polymers and their use as reagents in immunoassay systems
|
US4446232A
(en)
*
|
1981-10-13 |
1984-05-01 |
Liotta Lance A |
Enzyme immunoassay with two-zoned device having bound antigens
|
US4753875A
(en)
*
|
1981-11-02 |
1988-06-28 |
Ryan James W |
Method for assaying proteases with tagged proteinaceous inhibitors
|
US4506009A
(en)
*
|
1982-03-30 |
1985-03-19 |
University Of California |
Heterogeneous immunoassay method
|
US4469787A
(en)
*
|
1982-05-14 |
1984-09-04 |
Mallinckrodt Inc. |
Immunoassay involving soluble complex of second antibody and labeled binding protein
|
US4503143A
(en)
*
|
1982-08-20 |
1985-03-05 |
Btc Diagnostics Limited Partnership |
Enzyme immunoassay with two-part solution of tetramethylbenzidine as chromogen
|
US4530900A
(en)
*
|
1982-09-13 |
1985-07-23 |
Seragen Diagnostics Inc. |
Soluble insoluble polymers in enzymeimmunoassay
|
FR2550799B1
(fr)
*
|
1983-08-17 |
1986-02-21 |
Commissariat Energie Atomique |
Compose marque par une enzyme, son procede de preparation et son utilisation en enzymoimmunologie
|
WO1985002260A1
(fr)
*
|
1983-11-08 |
1985-05-23 |
Quidel |
Appareil et procede d'analyse immunologique a plongeur rapide
|
US4777240A
(en)
*
|
1984-03-08 |
1988-10-11 |
Scripps Clinic And Research Foundation |
SV40 expression vector containing HBxAg as an expression marker
|
US4645828A
(en)
|
1984-03-23 |
1987-02-24 |
Oncogen |
Platelet related growth regulator
|
US4665020A
(en)
*
|
1984-05-30 |
1987-05-12 |
United States Department Of Energy |
Flow cytometer measurement of binding assays
|
US4812395A
(en)
*
|
1984-11-05 |
1989-03-14 |
E. I. Du Pont De Nemours And Company |
Method for detecting enzymatic activity using particle agglutination
|
US4812396A
(en)
*
|
1984-11-05 |
1989-03-14 |
E. I. Du Pont De Nemours And Company |
Method for detecting enzymatic activity using particle agglutination
|
US4713347A
(en)
*
|
1985-01-14 |
1987-12-15 |
Sensor Diagnostics, Inc. |
Measurement of ligand/anti-ligand interactions using bulk conductance
|
US4824784A
(en)
*
|
1985-04-08 |
1989-04-25 |
Hygeia Sciences, Incorporated |
Chromogenic solution for immunoassay
|
US4837395A
(en)
*
|
1985-05-10 |
1989-06-06 |
Syntex (U.S.A.) Inc. |
Single step heterogeneous assay
|
US4931385A
(en)
*
|
1985-06-24 |
1990-06-05 |
Hygeia Sciences, Incorporated |
Enzyme immunoassays and immunologic reagents
|
US4868108A
(en)
*
|
1985-12-12 |
1989-09-19 |
Hygeia Sciences, Incorporated |
Multiple-antibody detection of antigen
|
CH670709A5
(fr)
*
|
1986-04-24 |
1989-06-30 |
Univ Moskovsk |
|
US5039607A
(en)
*
|
1988-05-17 |
1991-08-13 |
Syntex (U.S.A.) Inc. |
Method for immunochromatographic analysis
|
US5334513A
(en)
*
|
1988-05-17 |
1994-08-02 |
Syntex (U.S.A.) Inc. |
Method for immunochromatographic analysis
|
US5102788A
(en)
*
|
1988-11-21 |
1992-04-07 |
Hygeia Sciences, Inc. |
Immunoassay including lyophilized reactant mixture
|
US5135863A
(en)
*
|
1988-12-23 |
1992-08-04 |
Syntex (U.S.A.) Inc. |
Compositions and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine
|
US5614504A
(en)
*
|
1990-08-01 |
1997-03-25 |
The University Of South Florida |
Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
|
WO1992020820A1
(fr)
*
|
1991-05-15 |
1992-11-26 |
Vanderbilt University |
Methode de determination du potentiel metastatique des cellules tumorales
|
US5348867A
(en)
*
|
1991-11-15 |
1994-09-20 |
George Georgiou |
Expression of proteins on bacterial surface
|
US5874423A
(en)
*
|
1992-09-10 |
1999-02-23 |
Yissum Research Development Co. Of The Hebrew University Of Jerusalem |
Digitalis-like compounds
|
US5801005A
(en)
*
|
1993-03-17 |
1998-09-01 |
University Of Washington |
Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
|
US6953573B1
(en)
|
1993-03-17 |
2005-10-11 |
University Of Washington |
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
|
US5869445A
(en)
*
|
1993-03-17 |
1999-02-09 |
University Of Washington |
Methods for eliciting or enhancing reactivity to HER-2/neu protein
|
AU679008B2
(en)
*
|
1993-05-06 |
1997-06-19 |
Chiron Diagnostics Corporation |
Mixed luminescent conjugate test assays
|
WO1995034640A1
(fr)
*
|
1994-06-13 |
1995-12-21 |
Henry Ford Health System |
Neuronatine, nouveau gene neuronal neonatal
|
US5698686A
(en)
|
1994-10-20 |
1997-12-16 |
Arch Development Corporation |
Yeast telomerase compositions
|
US6531277B2
(en)
|
1994-10-25 |
2003-03-11 |
The Curators Of The University Of Missouri |
Endometriosis-specific secretory protein
|
US5843673A
(en)
*
|
1994-10-25 |
1998-12-01 |
Curators Of The University Of Missouri |
Method of screening for endometriosis
|
US20030152909A1
(en)
*
|
1994-11-16 |
2003-08-14 |
Mitrani Eduardo N. |
In vitro micro-organs, and uses related thereto
|
US5728807A
(en)
*
|
1995-05-16 |
1998-03-17 |
Ramot-University Authority For Applied Research And Industrial Development, Ltd. |
Mutated proteins associated with ataxia-telangiectasia
|
US5858661A
(en)
*
|
1995-05-16 |
1999-01-12 |
Ramot-University Authority For Applied Research And Industrial Development |
Ataxia-telangiectasia gene and its genomic organization
|
US5777093A
(en)
*
|
1995-05-16 |
1998-07-07 |
Ramot-University Authority For Applied Research & Industrial Development Ltd. |
cDNAs associated with ataxia-telangiectasia
|
US5807552A
(en)
*
|
1995-08-04 |
1998-09-15 |
Board Of Regents, The University Of Texas System |
Compositions for conferring immunogenicity to a substance and uses thereof
|
US6689757B1
(en)
|
1996-02-12 |
2004-02-10 |
M.L. Laboratories Plc |
Methods for vaccination and vaccines therefor
|
US6942862B2
(en)
*
|
1996-04-01 |
2005-09-13 |
University Of Washington |
Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
|
US20050214827A1
(en)
*
|
1996-07-08 |
2005-09-29 |
Burstein Technologies, Inc. |
Assay device and method
|
US6342349B1
(en)
|
1996-07-08 |
2002-01-29 |
Burstein Technologies, Inc. |
Optical disk-based assay devices and methods
|
US6331275B1
(en)
|
1996-07-08 |
2001-12-18 |
Burstein Technologies, Inc. |
Spatially addressable, cleavable reflective signal elements, assay device and method
|
CN1230216A
(zh)
|
1996-07-08 |
1999-09-29 |
伯斯坦恩实验室股份有限公司 |
可断裂信号元件装置和方法
|
US20050069923A1
(en)
*
|
1996-07-08 |
2005-03-31 |
Mullis Kary Banks |
Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus
|
US5840322A
(en)
*
|
1996-12-19 |
1998-11-24 |
Ramot-University Authority For Applied Research & Industrial Devel. Ltd. |
Anti-oral-microbial adhesion fraction derived from vaccinium
|
AU9028298A
(en)
*
|
1997-08-21 |
1999-03-08 |
Quark Biotech, Inc. |
Hypoxia-regulated genes
|
US6610838B1
(en)
|
1997-09-10 |
2003-08-26 |
Symbicom Aktiebolag |
P13 antigens from Borrelia
|
US6284496B1
(en)
|
1997-10-03 |
2001-09-04 |
University Of South Florida |
DNA vector for determining the presence of out-of-reading-frame mutations
|
US6482389B1
(en)
|
1997-10-17 |
2002-11-19 |
University Of South Florida |
Method to diagnose and monitor cellular immune deficiencies
|
US7687057B2
(en)
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
US20080206206A1
(en)
|
1998-05-07 |
2008-08-28 |
University Of South Florida |
Bone marrow-derived neuronal cells
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
US7605149B1
(en)
|
1998-07-13 |
2009-10-20 |
University Of South Florida |
Modulation of the phospholipase A2 pathway as a therapeutic
|
EP1097378A2
(fr)
*
|
1998-07-21 |
2001-05-09 |
Burstein Laboratories Inc. |
Dispositifs de dosage utilisant des disques optiques et methodes correspondantes
|
CA2303855A1
(fr)
|
1998-07-22 |
2000-02-03 |
Jin Po Lee |
Dispositif permettant de deceler differents composants
|
US6187563B1
(en)
|
1998-08-07 |
2001-02-13 |
Yale University |
βIV-spectrin-polypeptides and nucleic acids encoding same
|
JP2003523166A
(ja)
*
|
1998-09-29 |
2003-08-05 |
ガミダ セル リミテッド |
幹細胞および前駆細胞の増殖と分化を制御する方法
|
EP1131633A2
(fr)
*
|
1998-11-16 |
2001-09-12 |
Board of Regents, The University of Texas System |
Induction de lymphocytes t specifiques du vih
|
RU2249039C2
(ru)
*
|
1999-02-04 |
2005-03-27 |
Текнион Рисерч Энд Дивелопмент Фаундейшн Лтд. |
Способ размножения/поддержания недифференцированных гемопоэтических стволовых клеток или клеток-предшественников (варианты), способ приготовления кондиционированной среды стромальных клеток, способ трансплантации недифференцированных гемопоэтических стволовых клеток или клеток-предшественников (варианты)
|
US6440682B1
(en)
*
|
1999-05-28 |
2002-08-27 |
Detroit R&D Inc. |
Detection of hypertension using immunoreactive metabolic products
|
US6787318B1
(en)
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
US7534605B2
(en)
*
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
WO2001000859A1
(fr)
*
|
1999-06-25 |
2001-01-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Procede permettant d'induire une angiogenese au moyen de micro-organes
|
US6875582B1
(en)
|
1999-08-19 |
2005-04-05 |
Omniscience Pharmaceuticals, Inc. |
Methods and targets of antibiotic resistance
|
US7811981B2
(en)
|
1999-08-30 |
2010-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US7101839B1
(en)
|
1999-08-30 |
2006-09-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
US7167615B1
(en)
|
1999-11-05 |
2007-01-23 |
Board Of Regents, The University Of Texas System |
Resonant waveguide-grating filters and sensors and methods for making and using same
|
CA2392060C
(fr)
|
1999-11-19 |
2007-07-10 |
Yissum Research Development Company Of The Hebrew University In Jerusalem |
Gene et proteine de beta-glucosidase d'aspergillus niger et leurs utilisations
|
US6544506B2
(en)
|
2000-01-05 |
2003-04-08 |
Yeda Research & Development Co. Ltd. |
Veto cells effective in preventing graft rejection and devoid of graft versus host potential
|
US7385106B2
(en)
*
|
2000-01-24 |
2008-06-10 |
Ramot At Tel Aviv University Ltd. |
Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
|
US20040191260A1
(en)
*
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
CA2404489A1
(fr)
|
2000-03-27 |
2001-10-04 |
Technion Research And Development Foundation Ltd. |
Complexes majeurs d'histocompatibilite monocatenaires de classe 1, constructions les codant et leurs methodes de production
|
IL135884A
(en)
*
|
2000-04-30 |
2005-08-31 |
Yissum Res Dev Co |
Method for measuring non-transferrin bound iron
|
HUP0300810A2
(hu)
|
2000-07-20 |
2003-08-28 |
M.G.V.S. Ltd. |
Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
EP2359853B1
(fr)
|
2000-08-08 |
2013-11-06 |
Technion Research and Development Foundation, Ltd. |
Compositions pharmaceutiques et procédés utiles pour la modulation d'angiogénèse
|
US20030114410A1
(en)
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
EP1683874A3
(fr)
|
2000-08-29 |
2006-10-11 |
YEDA RESEARCH AND DEVELOPMENT Co. LTD. |
Méthode pour l'isolement de gènes codant pour des protéines à fonction spécifique et pour le criblage d'agents pharmaceutiques actifs
|
US20070281037A9
(en)
*
|
2000-09-28 |
2007-12-06 |
Nanocyte Inc. |
Sterile preparations and compositions including stinging capsules and methods of producing and using same
|
US7632522B2
(en)
*
|
2000-09-28 |
2009-12-15 |
Nanocyte Inc. |
Use of stinging cells/capsules for the delivery of active agents to keratinous substances
|
EP1379127B1
(fr)
*
|
2000-09-28 |
2013-04-17 |
Nanocyte Inc. |
Procedes, compositions et dispositifs utilisant des cellules/capsules urticantes pour administrer un agent therapeutique ou cosmetique dans un tissu
|
US7060462B2
(en)
*
|
2000-11-02 |
2006-06-13 |
National University Of Singapore |
AopB gene, protein,homologs, fragments and variants thereof, and their use for cell surface display
|
US8071740B2
(en)
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
EP2186530B1
(fr)
|
2000-11-17 |
2013-05-22 |
Vascular Biogenics Ltd. |
Promoteurs présentant une specificité pour des cellules endotheliales et procédés d'utilisation desdits promoteurs
|
JP4162486B2
(ja)
|
2000-11-24 |
2008-10-08 |
ヴァスキュラー バイオジェニックス リミテッド |
アテローム性動脈硬化を防止および処置するための規定された酸化型リン脂質を用いる方法およびそのような酸化型リン脂質を含有する組成物
|
US20040248093A1
(en)
*
|
2000-11-27 |
2004-12-09 |
Coombs James Howard |
Magneto-optical bio-discs and systems including related methods
|
US20020172980A1
(en)
*
|
2000-11-27 |
2002-11-21 |
Phan Brigitte Chau |
Methods for decreasing non-specific binding of beads in dual bead assays including related optical biodiscs and disc drive systems
|
US20030003464A1
(en)
*
|
2000-11-27 |
2003-01-02 |
Phan Brigitte C. |
Dual bead assays including optical biodiscs and methods relating thereto
|
KR20030067696A
(ko)
|
2000-11-30 |
2003-08-14 |
모렉큐랄 스킨케어 리미티드 |
질병의 진단 및 치료
|
IL155941A0
(en)
*
|
2000-11-30 |
2003-12-23 |
Yeda Res & Dev |
Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
|
WO2002047535A2
(fr)
*
|
2000-12-14 |
2002-06-20 |
Nyxis Neurotherapies, Inc. |
Criblage a haut debit pour detection d'inhibiteurs de la voie des proteine-kinases activees par des mitogenes (mapk)
|
US7087395B1
(en)
|
2001-01-16 |
2006-08-08 |
Quest Diagnostics Investments Incorporated |
Vitamin D assay
|
US20050202098A1
(en)
*
|
2001-01-31 |
2005-09-15 |
Tolaren |
Disease therapy using dying or dead cells
|
AU2002230061A1
(en)
*
|
2001-01-31 |
2002-08-12 |
Tolaren |
Induction of tolerance by apoptotic and/or necrotic cells
|
US20030003454A1
(en)
|
2001-03-23 |
2003-01-02 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
|
CN1639557A
(zh)
|
2001-04-11 |
2005-07-13 |
伯斯坦技术公司 |
包括分析盘的多参数化验以及涉及该化验的方法
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
US20050022269A1
(en)
*
|
2001-07-19 |
2005-01-27 |
Joseph Hirschberg |
Polypeptides having carotenoids isomerase catalytic activity, nucleic acids encoding same and uses thereof
|
WO2003017817A2
(fr)
|
2001-08-16 |
2003-03-06 |
Bar Ilan University |
Diagnostic, prevention et traitement du cancer
|
US7138144B2
(en)
*
|
2001-09-07 |
2006-11-21 |
Nadir Askenasy |
Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
|
US20040136972A1
(en)
|
2001-09-07 |
2004-07-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
|
EP1436313B1
(fr)
|
2001-10-19 |
2010-09-22 |
Vascular Biogenics Ltd. |
Constructions de polynucleotides, compositions pharmaceutiques et procedes de regulation negative de l'angiogenese et de therapie anticancereuse
|
AUPR842501A0
(en)
*
|
2001-10-23 |
2001-11-15 |
Epipop Pty Ltd |
A method for identification and development of therapeutic agents
|
US6867005B2
(en)
|
2001-10-24 |
2005-03-15 |
Beckman Coulter, Inc. |
Method and apparatus for increasing the dynamic range and accuracy of binding assays
|
US6696254B2
(en)
|
2001-11-21 |
2004-02-24 |
Kimberly-Clark Worldwide, Inc. |
Detection and identification of enteric bacteria
|
WO2003048298A2
(fr)
*
|
2001-12-05 |
2003-06-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nanoparticules contenant des homologues d'acides nucleiques polymeres, compositions pharmaceutiques et articles fabriques contenant ces nanoparticules, et procedes d'utilisation de celles-ci
|
US20050085432A1
(en)
*
|
2001-12-26 |
2005-04-21 |
Aviva Lapidot |
Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
|
IL152904A0
(en)
*
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
WO2003062404A1
(fr)
*
|
2002-01-25 |
2003-07-31 |
Gamida-Cell Ltd. |
Methodes de developpement de cellules souches et de cellules precurseurs, populations de cellules multipliees obtenues a l'aide de ces methodes
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
EP1485075A4
(fr)
*
|
2002-02-20 |
2006-04-26 |
Dyax Corp |
Ligands de liaison au complexe mhc-peptide
|
SI1487972T1
(sl)
|
2002-02-21 |
2016-03-31 |
Institute Of Virology Slovak Academy Of Sciences |
Monoklonska protitelesa, specifična za MN/CA IX, proizvedena iz MN/CA IX deficientnih miši, in postopki uporabe
|
CA2479679A1
(fr)
*
|
2002-03-18 |
2003-09-25 |
Gamida-Cell Ltd. |
Procedes permettant d'induire la differenciation dans des cellules souches expansees ex vivo
|
ATE394125T1
(de)
*
|
2002-03-26 |
2008-05-15 |
Nanocyte Inc |
Nesselzellen mit expression eines exogenen polynucleotids, das ein therapeutisches, diagnostisches oder kosmetisches mittel kodiert, und diese nesselzellen verwendende verfahren, zusammensetzungen und vorrichtungen oder daraus gewonnene kapseln zur abgabe des therapeutischen, diagnostischen oder kosmetischen mittels in ein gewebe
|
AU2003230925A1
(en)
*
|
2002-04-16 |
2003-11-03 |
The Regents Of The University Of California |
Methods or renal cell carcinoma prognosis and treatment selection with carbonic anhydrase ix
|
US20040121442A1
(en)
*
|
2002-05-05 |
2004-06-24 |
Ilan Chet |
Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
|
AU2003242967A1
(en)
*
|
2002-07-12 |
2004-02-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method and device for inducing biological processes by micro-organs
|
CA2494348C
(fr)
|
2002-08-01 |
2014-04-08 |
Yeda Research And Development Co. Ltd. |
Methode et composition pour la protection du tissu neuronal contre une lesion induite par des taux de glutamate eleves
|
AU2003265523A1
(en)
|
2002-08-20 |
2004-03-11 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
US7267981B2
(en)
|
2002-10-07 |
2007-09-11 |
Technion Research & Development Foundation Ltd. |
Human foreskin fibroblasts for culturing ES cells
|
US20040146949A1
(en)
*
|
2002-10-25 |
2004-07-29 |
Jun Tan |
Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of alzheimer's disease
|
CA2504512A1
(fr)
|
2002-10-30 |
2004-05-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Molecules et leurs procedes d'utilisation pour la mesure de fer non lie par la transferrine
|
US20050054097A1
(en)
*
|
2002-11-17 |
2005-03-10 |
Tony Peled |
EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
|
AU2003302701A1
(en)
*
|
2002-11-29 |
2004-06-23 |
Technion Research And Development Foundation Ltd. |
Method of dynamically culturing embryonic stem cells
|
US7491699B2
(en)
*
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
JP4676202B2
(ja)
|
2002-12-12 |
2011-04-27 |
アール.ビー.ティー (ラクト バイオ テクノロジーズ) リミテッド |
リグニンペルオキシオダーゼの製造方法ならびに皮膚および毛髪の明色化におけるその使用
|
CA2508880C
(fr)
|
2002-12-16 |
2018-02-06 |
Technion Research And Development Foundation Ltd. |
Procedes pour preparer des cellules souches embryonnaires humaines exemptes de cellules nourricieres et de xeno-contaminants et cultures de cellules souches preparees au moyen de ces procedes
|
EP2292762A3
(fr)
|
2002-12-20 |
2012-12-12 |
Board of Regents, The University of Texas System |
Séquences d'espèces et de souches de Borrelia pathogène de type VMP
|
CA2512499A1
(fr)
|
2003-01-02 |
2004-07-22 |
Rappaport Family Institute For Research In The Medical Sciences |
Methodes de prediction de potentiel a tirer benefice d'un traitement antioxydant pour la prevention de maladies cardiovasculaires chez des patients hyperglycemiques
|
ATE426575T1
(de)
|
2003-01-07 |
2009-04-15 |
Univ Ramot |
Peptidenanostrukturen die fremdmaterial enthalten,und verfahren zur herstellung derselben
|
WO2004106925A2
(fr)
*
|
2003-03-03 |
2004-12-09 |
Nagaoka & Co.Ltd. |
Procedes et appareil utilises pour la detection et la quantification de divers types de cellules et utilisation d'un bio-disque optique pour leur mise en oeuvre
|
EP1599598A4
(fr)
|
2003-03-04 |
2007-08-08 |
Yeda Res & Dev |
Polypeptides pon, polynucleotides les codant et compositions et procedes utilisant ces derniers
|
EP1601759A4
(fr)
*
|
2003-03-07 |
2007-02-14 |
Gamida Cell Ltd |
Extension de populations de cellules souches renouvelables au moyen de modulateurs de kinase pi 3
|
US8017113B2
(en)
|
2003-03-12 |
2011-09-13 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions and methods for diagnosing and treating an inflammation
|
US7294701B2
(en)
*
|
2003-04-02 |
2007-11-13 |
Technion Research & Development Foundation Ltd. |
Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
|
WO2004087042A2
(fr)
|
2003-04-04 |
2004-10-14 |
Yeda Research And Development Co. Ltd. |
Anticorps et compositions pharmaceutiques contenant ces derniers utiles pour inhiber l'activite de metalloproteines
|
ES2559053T3
(es)
|
2003-04-08 |
2016-02-10 |
Yeda Research And Development Co., Ltd. |
Células madre con aumento de sensibilidad a SDF-1 y procedimientos de generación y utilización de las mismas
|
FR2853551B1
(fr)
|
2003-04-09 |
2006-08-04 |
Lab Francais Du Fractionnement |
Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
US20050002953A1
(en)
*
|
2003-05-06 |
2005-01-06 |
Jens Herold |
SARS-coronavirus virus-like particles and methods of use
|
CA2978152C
(fr)
|
2003-05-22 |
2021-01-26 |
Evogene Ltd. |
Procedes d'augmentation de la tolerance du stress abiotique des plantes et plantes ainsi produites
|
US7554007B2
(en)
|
2003-05-22 |
2009-06-30 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants
|
AU2005234725B2
(en)
|
2003-05-22 |
2012-02-23 |
Evogene Ltd. |
Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
|
EP1635765B1
(fr)
|
2003-05-23 |
2013-07-17 |
Board Of Regents, The University Of Texas System |
Oligonucleoside phosphorothioate selectionnes de maniere combinatoire et a base structurelle et facteurs de transcription ap-1 ciblant un phosphorodithioate aptamere
|
US20050020499A1
(en)
*
|
2003-05-27 |
2005-01-27 |
Bar Ilan University |
Methods of attenuating cocaine seeking behavior employing glial cell-derived neurotrophic factor (GDNF) and pharmaceutical compositions and articles of manufacture suited for use in practice of the method
|
EP1636333A4
(fr)
*
|
2003-06-19 |
2007-10-24 |
Evogene Ltd |
Sequences nucleotidiques pour reguler l'expression genetique chez des trichromes vegetaux, et genes hybrides et procedes dans lesquels elles interviennent
|
US8129514B2
(en)
*
|
2003-06-19 |
2012-03-06 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
EP2719394B1
(fr)
|
2003-06-30 |
2015-07-29 |
Tel Aviv University Future Technology Development L.P. |
Peptides pour traiter des maladies associées aux amyloïdes
|
US20070041971A1
(en)
*
|
2003-07-07 |
2007-02-22 |
Wagner David H |
Methods for predicting development of auto-immune diseases and treatment of same
|
CA2535951A1
(fr)
*
|
2003-08-14 |
2005-03-03 |
The Bio Balance Corporation |
Souches bacteriennes, compositions les comprenant et leur utilisation dans un traitement probiotique
|
WO2005031362A2
(fr)
|
2003-10-02 |
2005-04-07 |
Ramot At Tel Aviv University Ltd. |
Nouveaux agents antibacteriens et procedes permettant de les identifier et de les utiliser
|
PL1678209T3
(pl)
|
2003-10-07 |
2011-09-30 |
Yeda Res & Dev |
Przeciwciała skierowane przeciwko NIK, ich wytwarzanie i zastosowanie
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
MXPA06004537A
(es)
*
|
2003-10-23 |
2006-06-23 |
Pfizer Prod Inc |
Vacuna para la enfermedad periodontal.
|
WO2005044855A2
(fr)
|
2003-11-04 |
2005-05-19 |
Chiron Corporation |
Utilisation d'anticorps monoclonaux antagonistes anti-cd40 pour le traitement de myelome multiple
|
EP2248830A1
(fr)
|
2003-11-04 |
2010-11-10 |
Novartis Vaccines and Diagnostics, Inc. |
Utilisation d'anticorps antagonistes anti-CD40 pour le traitement de maladies autoimmunes et inflammatoires et le rejet d'organes transplantés
|
EP1680141B8
(fr)
|
2003-11-04 |
2011-01-12 |
Novartis Vaccines and Diagnostics, Inc. |
Procedes therapeutiques de tumeurs solides exprimant l'antigene de surface cellulaire cd40
|
DK1682177T3
(da)
|
2003-11-04 |
2010-11-01 |
Novartis Vaccines & Diagnostic |
Anvendelse af antagonist-anti-CD40-antistoffer til behandling af kronisk lymfocytisk leukæmi
|
WO2005051423A2
(fr)
|
2003-11-30 |
2005-06-09 |
Yeda Research And Development Co. Ltd |
Procedes et agents pour mettre en oeuvre une modulation immunitaire et procedes d'identification de modulateurs immunitaires
|
WO2005059100A2
(fr)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Procedes et compositions se rapportant a la cystatine c
|
US20100221233A1
(en)
*
|
2003-12-15 |
2010-09-02 |
University Of South Florida |
Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
|
EP1722834B1
(fr)
|
2003-12-22 |
2012-06-27 |
Regentis Biomaterials Ltd. |
Matrice comprenant un squelette proteique reticule naturel
|
US8007847B2
(en)
*
|
2004-01-13 |
2011-08-30 |
Eytan Biderman |
Feeding formula appliance
|
US7423139B2
(en)
*
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
EP2816351A3
(fr)
*
|
2004-01-27 |
2015-03-25 |
Compugen Ltd. |
Procédés et systèmes d'annotation de séquences biomoléculaires
|
AU2005219441A1
(en)
|
2004-03-02 |
2005-09-15 |
Acceleron Pharma Inc. |
ALK7 and myostatin inhibitors and uses thereof
|
US8352031B2
(en)
|
2004-03-10 |
2013-01-08 |
Impulse Dynamics Nv |
Protein activity modification
|
ES2665463T3
(es)
|
2004-06-14 |
2018-04-25 |
Evogene Ltd. |
Polinucleótidos y polipéptidos implicados en el desarrollo de fibra vegetal y métodos de uso de los mismos
|
US8962915B2
(en)
|
2004-06-14 |
2015-02-24 |
Evogene Ltd. |
Isolated polypeptides, polynucleotides encoding same, transgenic plants expressing same and methods of using same
|
US8680062B2
(en)
*
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
US20090156471A1
(en)
*
|
2004-07-15 |
2009-06-18 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
EP2295973A1
(fr)
|
2004-09-08 |
2011-03-16 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services |
Compositions et procédés pour la détection d'une infection par VIH-1/VIH-2
|
EP1799812A4
(fr)
*
|
2004-09-16 |
2009-09-09 |
Gamida Cell Ltd |
Méthodes de culture ex vivo de cellules souches et de précurseur par co-culture avec des cellules mésenchymales
|
US20060095241A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Microsoft Corporation |
Systems and methods that utilize machine learning algorithms to facilitate assembly of aids vaccine cocktails
|
US8000900B2
(en)
|
2004-09-21 |
2011-08-16 |
Microsoft Corporation |
Association-based predictions of pathogen characteristics
|
EP3312282B1
(fr)
|
2004-09-29 |
2019-07-03 |
Collplant Ltd. |
Plantes produisant du collagene et procedes de generation et d'utilisation de celles-ci
|
BRPI0516302A
(pt)
*
|
2004-09-29 |
2008-09-02 |
Yissun Res Dev Company Of The |
rnase t2 humana recombinante e suas utilizações
|
WO2006040765A1
(fr)
*
|
2004-10-12 |
2006-04-20 |
Closed Loop Therapies Ltd. |
Methodes et dispositifs implantables pour traiter des arythmies supraventriculaires
|
US8478535B2
(en)
|
2004-10-29 |
2013-07-02 |
Microsoft Corporation |
Systems and methods that utilize machine learning algorithms to facilitate assembly of aids vaccine cocktails
|
WO2006048262A2
(fr)
*
|
2004-11-04 |
2006-05-11 |
Roche Diagnostics Gmbh |
Classification de la leucemie myeloblastique aigue
|
US7842794B2
(en)
|
2004-12-17 |
2010-11-30 |
Roche Molecular Systems, Inc. |
Reagents and methods for detecting Neisseria gonorrhoeae
|
US20060134680A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Alexander Kotlyar |
Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
|
EP1872604A4
(fr)
*
|
2005-01-16 |
2010-01-20 |
Zlango Ltd |
Systeme de reseau de communication et procedes d'utilisation
|
JP2008527563A
(ja)
*
|
2005-01-16 |
2008-07-24 |
ズランゴー リミテッド |
アイコニック通信
|
US8019818B2
(en)
*
|
2005-01-18 |
2011-09-13 |
Zlango Ltd. |
Communications network system and methods for using same
|
WO2006080021A2
(fr)
|
2005-01-31 |
2006-08-03 |
Realbio Technologies Ltd. |
Dispositif capillaire a flux lateral de reaction par etapes multiples
|
ES2366654T3
(es)
|
2005-02-17 |
2011-10-24 |
HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT CO., LTD. |
Biofosfonatos para tratar la endometriosis.
|
WO2006090388A2
(fr)
|
2005-02-25 |
2006-08-31 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center |
Composition pour administration par les muqueuses de cultures de cellules de fruit et de preparations tirees de ces cultures, et methodes de fabrication
|
US7695927B2
(en)
*
|
2005-03-18 |
2010-04-13 |
Detroit R & D |
Detection of hypertension using glucuronidated metabolic products
|
WO2006109312A2
(fr)
*
|
2005-04-15 |
2006-10-19 |
Vascular Biogenics Ltd. |
Compositions contenant des peptides derives de la glycoproteine i beta 2 pour la prevention et le traitement de maladie cardiovasculaire
|
US8834862B2
(en)
*
|
2005-04-19 |
2014-09-16 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
|
EP1889065B1
(fr)
|
2005-05-18 |
2013-07-10 |
Novartis AG |
Procédés de diagnostic et de traitement de maladies ayant une composante auto-immune et/ou inflammatoire
|
EP1888034A2
(fr)
|
2005-05-26 |
2008-02-20 |
Yissum Research Development Company, of The Hebrew University of Jerusalem |
Compositions et methodes d'utilisation desdites compositions dans l'administration d'agents dans un organe cible protege par une barriere sanguine
|
CN101243178A
(zh)
|
2005-06-16 |
2008-08-13 |
特拉维夫大学拉莫特有限公司 |
用于治疗cns疾病的分离细胞和包含这种细胞的细胞群
|
US20070225242A1
(en)
*
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
US20060292559A1
(en)
*
|
2005-06-23 |
2006-12-28 |
Beckman Coulter, Inc. |
Cell-based microarrays, and methods for their preparation and use
|
CA2614531C
(fr)
|
2005-07-07 |
2015-06-16 |
Avraham Hochberg |
Agents de type acide nucleique pour la regulation a la baisse de h19 et methodes d'emploi desdits agents
|
CA2613619A1
(fr)
|
2005-07-07 |
2007-01-18 |
Fulcrum Sp Ltd. |
Polypeptides sp1, polypeptides sp1 modifies et leurs utilisations
|
CN101278052A
(zh)
|
2005-07-18 |
2008-10-01 |
普罗塔里克斯有限公司 |
生物活性大分子的粘膜或肠给药
|
US7993657B2
(en)
|
2005-07-26 |
2011-08-09 |
University Of Medicine And Dentistry Of New Jersey |
Antibody profiles characteristic of tuberculosis state
|
EP1945257A4
(fr)
*
|
2005-08-08 |
2009-05-06 |
Onconon Llc |
Compositions d'anticorps, methodes de traitement de maladie neoplasique et methodes de regulation de la fertilite
|
EP1928479B1
(fr)
|
2005-08-24 |
2016-06-08 |
Yeda Research And Development Co., Ltd. |
Cellules tolerogeniques derivees de donneurs universels et destinees a induire une tolerance a la transplantation non syngenique
|
WO2007026353A2
(fr)
|
2005-08-29 |
2007-03-08 |
Technion Research & Development Foundation Ltd. |
Milieux de culture de cellules souches
|
ATE466079T1
(de)
*
|
2005-09-22 |
2010-05-15 |
Yissum Res Dev Co |
Nukleinsäure konstrukten, pharmazeutische kompositionen und methoden für die behandlung von krebs
|
US20070087437A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jifan Hu |
Methods for rejuvenating cells in vitro and in vivo
|
KR20080072748A
(ko)
|
2005-11-29 |
2008-08-06 |
가미다-셀 리미티드 |
줄기세포 귀소 및 생착을 향상시키는 방법
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
EP1977312A2
(fr)
|
2006-01-16 |
2008-10-08 |
Zlango Ltd. |
Communication iconique
|
EP2368570A3
(fr)
|
2006-01-18 |
2012-05-02 |
University Of Chicago |
Compositions et procédés liés aux protéines des bactéries staphylocoques
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
WO2007092252A2
(fr)
|
2006-02-03 |
2007-08-16 |
Modigene Inc |
Polypeptides a action prolongee et leurs procedes de production
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
JP2009526219A
(ja)
|
2006-02-06 |
2009-07-16 |
ラパポート ファミリー インスティテュート フォー リサーチ イン ザ メディカル サイエンシーズ |
T1dmを診断するための方法及びキット
|
JP5107943B2
(ja)
|
2006-03-06 |
2012-12-26 |
ゼティク テクノロジーズ リミテッド |
細胞の表現型を特定するための方法および組成物
|
SI2548951T1
(sl)
|
2006-03-23 |
2016-07-29 |
Pluristem Ltd. |
Postopki za celično ekspanzijo ter uporabe celic in kondicioniranih medijev, proizvedenih z njimi, za terapijo
|
WO2007110869A2
(fr)
|
2006-03-28 |
2007-10-04 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Procedes et kits pour determiner la predisposition a la resistance a la warfarine
|
EP2010567A2
(fr)
*
|
2006-04-07 |
2009-01-07 |
The Government of the United States of America as Represented by The Department of Health and Human Services |
Compositions d'anticorps et méthodes de traitement d'une maladie néoplasique
|
CA2649907A1
(fr)
|
2006-04-21 |
2007-11-01 |
Novartis Ag |
Compositions pharmaceutiques d'anticorps anti-cd40 antagoniste
|
KR101442209B1
(ko)
*
|
2006-05-19 |
2014-11-18 |
테크니온 리서치 엔드 디벨로프먼트 화운데이션 엘티디. |
융합 단백질, 이의 용도 및 이의 제조방법
|
US20070281883A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Hanna Rosenfeld |
Development of follicle stimulating hormone agonists and antagonists in fish
|
US8629259B2
(en)
|
2006-07-20 |
2014-01-14 |
Yeda Research And Development Co. Ltd. |
Photosynthetic organisms and compositions and methods of generating same
|
WO2008026198A2
(fr)
|
2006-08-28 |
2008-03-06 |
Yeda Research And Development Co. Ltd. |
Méthodes de production de cellules gliales et neuronales et leur utilisation pour le traitement de troubles médicaux du système nerveux central
|
EP2084261A1
(fr)
*
|
2006-09-08 |
2009-08-05 |
Wisconsin Alumni Research Foundation |
Analyse pour les anticorps envers le bacille de koch
|
US7888059B2
(en)
*
|
2006-10-05 |
2011-02-15 |
Yeda Research And Development Co. Ltd. |
Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
|
ES2426754T3
(es)
|
2006-10-05 |
2013-10-25 |
Technion Research & Development Foundation Ltd. |
Microtubos y métodos para producirlos
|
MX2009006660A
(es)
|
2006-12-20 |
2009-08-20 |
Evogene Ltd |
Polinucleotidos y polipeptidos involucrados en el desarrollo de fibra vegetal y metodos de uso.
|
GB0700133D0
(en)
|
2007-01-04 |
2007-02-14 |
Humabs Llc |
Human cytomegalovirus neutralising antibodies and use thereof
|
WO2008087642A2
(fr)
*
|
2007-01-16 |
2008-07-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Acides nucléiques recombinés et procédés de silençage spécifique de h19
|
US20100196403A1
(en)
*
|
2007-01-29 |
2010-08-05 |
Jacob Hochman |
Antibody conjugates for circumventing multi-drug resistance
|
WO2008093341A2
(fr)
|
2007-01-31 |
2008-08-07 |
Technion Research & Development Foundation Ltd. |
Échafaudages électrofilés et leurs procédés de génération et d'utilisation
|
EP2125050B1
(fr)
|
2007-02-01 |
2014-07-30 |
Technion Research & Development Foundation Ltd. |
Fibres et tissus d'albumine et leurs procédés de génération et d'utilisation
|
KR20090114430A
(ko)
|
2007-02-02 |
2009-11-03 |
베일러 리서치 인스티튜트 |
항원-제시 세포 상에서 발현된 dcir에 대한 항원 표적화에 기초한 백신
|
CA2715042C
(fr)
*
|
2007-02-02 |
2021-02-02 |
Baylor Research Institute |
Complexes d'antigenes multivariables et d'un anticorps monoclonal humanise cible
|
TWI422594B
(zh)
|
2007-02-02 |
2014-01-11 |
Baylor Res Inst |
經由樹狀細胞去唾液酸糖蛋白受體(dc-asgpr)接合抗原呈現細胞之藥劑
|
CN101668777A
(zh)
*
|
2007-02-23 |
2010-03-10 |
贝勒研究院 |
通过clec-6激活人抗原呈递细胞
|
EP2129773B1
(fr)
|
2007-02-23 |
2013-02-13 |
Baylor Research Institute |
Applications thérapeutiques des cellules présentant un antigène humain par l'intermédiaire de la dectine-1
|
CN101668772A
(zh)
|
2007-02-23 |
2010-03-10 |
贝勒研究院 |
通过树突细胞凝集素样氧化型ldl受体-1(lox-1)激活人抗原呈递细胞
|
ES2662036T3
(es)
|
2007-02-28 |
2018-04-05 |
Yeda Research And Development Company Limited |
Secuencias que se dirigen al núcleo
|
EP2144935A2
(fr)
|
2007-03-29 |
2010-01-20 |
Technion Research & Development Foundation Ltd. |
Anticorps, procédés et kits de diagnostic et de traitement de mélanomes
|
WO2008120216A1
(fr)
|
2007-04-02 |
2008-10-09 |
Ramot At Tel Aviv University Ltd. |
Procédés permettant de détecter des cellules cancéreuses et leur utilisation pour diagnostiquer et surveiller le traitement de la maladie
|
WO2008122980A2
(fr)
*
|
2007-04-09 |
2008-10-16 |
Evogene Ltd. |
Polynucléotides, polypeptides et procédés permettant d'augmenter la teneur en huile, la vitesse de croissance et la biomasse de plantes
|
WO2008129548A2
(fr)
*
|
2007-04-23 |
2008-10-30 |
Segev Laboratories Limited |
Système pour administrer des agents thérapeutiques dans des cellules vivantes et noyaux de cellules
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
US8338113B2
(en)
|
2007-05-01 |
2012-12-25 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods for detecting fetal cells in the maternal blood
|
EP2150276B1
(fr)
|
2007-05-03 |
2014-05-21 |
Agency For Science, Technology And Research |
Fixation d'anticorps sur un polypeptide prl-1 ou prl-3 intracellulaire
|
BRPI0810343B1
(pt)
|
2007-05-07 |
2021-03-30 |
Protalix Ltd |
Dispositivo descartável para o cultivo e colheita de tecidos vegetais e/ou células, método de cultivo e colheita de um tecido vegetal e/ou células vegetais em um volume maior do que 400 litros e sistema de cultivo da célula vegetal
|
US20100197767A1
(en)
|
2007-07-11 |
2010-08-05 |
Lior Nissim |
Nucleic acid construct systems capable of daignosing or treating a cell state
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
WO2009010968A2
(fr)
|
2007-07-15 |
2009-01-22 |
Yitzchak Hillman |
Traitement de maladie par des peptides antimicrobien ou leurs inhibiteurs
|
BRPI0812742B1
(pt)
|
2007-07-24 |
2021-04-20 |
Evogene Ltd |
método de aumento da biomassa, da taxa de crescimento, da produtividade de semente, da eficiência do uso de nitrogênio, do estresse abiótico de uma planta, do comprimento de raiz, da cobertura de raiz, da taxa de crescimento da área de roseta, e da taxa de crescimento do diâmetro da roseta de uma planta
|
SI2182981T1
(sl)
*
|
2007-08-02 |
2013-05-31 |
Gilead Biologics, Inc. |
Postopki in sestavki za zdravljenje in diagnozo fibroze
|
CN102083455B
(zh)
|
2007-08-15 |
2015-01-07 |
耶达研究及发展有限公司 |
Mmp-9的调节剂及其用途
|
WO2009072001A2
(fr)
*
|
2007-09-12 |
2009-06-11 |
Aurelium Biopharma Inc. |
Diagnostics dirigés contre slc9a3r1 pour une maladie néoplasique
|
US8741315B2
(en)
|
2007-09-12 |
2014-06-03 |
Yeda Research And Development Co. Ltd. |
Methods of treating tumors in immune-privileged sites
|
PL2200622T5
(pl)
|
2007-09-19 |
2016-08-31 |
Pluristem Ltd |
Adherentne komórki z tkanki tłuszczowej i łożyska i ich zastosowanie w terapii
|
CA2702655A1
(fr)
|
2007-10-19 |
2009-04-23 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions comprenant des semaphorines pour le traitement de maladies associees a l'angiogenese et leurs procedes de selection
|
WO2009059328A2
(fr)
*
|
2007-11-02 |
2009-05-07 |
The Johns Hopkins University |
Vaccin l2 multicomposant pour la prévention d'une infection de papillomavirus humain
|
WO2009069123A2
(fr)
|
2007-11-26 |
2009-06-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions renfermant des polypeptides fibreux et des polysaccharides
|
MX357387B
(es)
|
2007-12-27 |
2018-07-06 |
Evogene Ltd |
Polipeptidos, polinucleotidos aislados utiles para modificar la eficacia en el uso de agua, eficacia en el uso del fertilizante, la tolerancia al estres biotico/abiotico, el rendimiento y biomasa en plantas.
|
US20090233295A1
(en)
*
|
2008-01-29 |
2009-09-17 |
Elias Georges |
Trim59 directed diagnostics for neoplastic disease
|
AU2009208607B2
(en)
*
|
2008-01-31 |
2013-08-01 |
Compugen Ltd. |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
US9297094B2
(en)
|
2008-02-21 |
2016-03-29 |
Technion Research & Development Foundation Ltd. |
Use of electrospun microtubes for drug delivery
|
CA2718107A1
(fr)
*
|
2008-03-18 |
2009-09-24 |
Wisconsin Alumini Research Foundation |
Test de criblage de culture mycobacterienne pour une bacterie complexe de mycobacterium avium
|
US20110033473A1
(en)
*
|
2008-04-09 |
2011-02-10 |
Yoram Reiter |
Anti influenza antibodies and uses thereof
|
WO2009125394A1
(fr)
*
|
2008-04-09 |
2009-10-15 |
Technion Research & Development Foundation Ltd. |
Anticorps anti-immunodéficience humaine et leurs utilisations
|
WO2009125381A1
(fr)
*
|
2008-04-10 |
2009-10-15 |
Objet Geometries Ltd. |
Système et procédé pour l’impression de modèles en trois dimensions
|
ES2565185T3
(es)
|
2008-04-18 |
2016-04-01 |
Collplant Ltd. |
Métodos de generación y de uso del procolágeno
|
BRPI0907261A2
(pt)
|
2008-04-21 |
2019-09-24 |
Danziger Innovations Ltd |
"vetores de expressão viral de plantas e o uso dos mesmos para gerar variações genotípicas em genomas de plantas"
|
SG176464A1
(en)
|
2008-05-09 |
2011-12-29 |
Agency Science Tech & Res |
Diagnosis and treatment of kawasaki disease
|
ES2674256T3
(es)
*
|
2008-05-22 |
2018-06-28 |
Evogene Ltd. |
Polinucleótidos y polipéptidos aislados y métodos de uso de los mismos para aumentar el rendimiento de la planta
|
CA2725637A1
(fr)
|
2008-05-27 |
2009-12-03 |
Pluristem Ltd. |
Procedes de traitement de maladies inflammatoires du colon
|
DK2620493T3
(da)
|
2008-05-28 |
2019-07-01 |
Univ Ramot |
Mesenkymale stamceller til behandling af CNS-sygdomme
|
WO2010007613A1
(fr)
|
2008-06-29 |
2010-01-21 |
Realbio Technologies Ltd. |
Dispositif de transfert de liquide particulièrement utile comme dispositif de capture dans un processus de dosage biologique
|
MX343490B
(es)
|
2008-07-16 |
2016-11-08 |
Inst For Res In Biomedicine |
Anticuerpos neutralizantes de citomegalovirus humano y uso de los mismos.
|
MX2011000542A
(es)
|
2008-07-16 |
2011-08-03 |
Humabs Llc |
Citomegalovirus humano que neutraliza anticuerpos y su uso.
|
KR101548143B1
(ko)
|
2008-07-16 |
2015-08-28 |
베일러 리서치 인스티튜트 |
극대화된 Gag 및 Nef를 수지상 세포에 표적화시킴을 기본으로 하는 HIV 백신
|
KR101732056B1
(ko)
*
|
2008-07-25 |
2017-05-02 |
인스티튜트 포 리서치 인 바이오메드슨 |
중화 항-인플루엔자 a 바이러스 항체 및 이의 용도
|
US8871207B2
(en)
|
2008-07-25 |
2014-10-28 |
Humabs, LLC |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
CN102176914B
(zh)
|
2008-08-08 |
2014-12-17 |
新加坡科技研究局 |
用于诊断和治疗癌症的vhz
|
AU2009279458B2
(en)
|
2008-08-08 |
2015-07-02 |
Code Biotherapeutics, Inc. |
Long-acting DNA dendrimers and methods thereof
|
BR122021014175B1
(pt)
|
2008-08-18 |
2022-09-20 |
Evogene Ltd. |
Método para aumentar a eficiência de uso do nitrogênio, eficiência de uso de fertilizantes, produção, taxa de crescimento, vigor, biomassa, teor de óleo e/ou tolerância ao estresse de deficiência de nitrogênio de uma planta
|
RU2539786C2
(ru)
|
2008-09-02 |
2015-01-27 |
Плуристем Лтд. |
Выращенные в прикрепленной к субстрату культуре клетки из ткани плаценты и их использование при лечении
|
US8367392B2
(en)
*
|
2008-09-05 |
2013-02-05 |
Transalgae Ltd. |
Genetic transformation of algal and cyanobacteria cells by microporation
|
EP2326340A4
(fr)
|
2008-09-11 |
2013-01-23 |
Univ Ben Gurion |
Compositions et procédés destinés à traiter une infection par s. pneumoniae
|
CN107595889A
(zh)
|
2008-09-12 |
2018-01-19 |
克里奥普拉斯低温生物有限公司 |
缺血性组织的细胞疗法
|
SG10202000552YA
(en)
|
2008-09-24 |
2020-03-30 |
Tel Hashomer Medical Research Infrastructure And Services Ltd |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
US20110178024A1
(en)
|
2008-09-29 |
2011-07-21 |
Ben Gurion University Of The Negev Research And Development Authority |
Amyloid beta-peptides and methods of use thereof
|
CA2739581A1
(fr)
|
2008-10-06 |
2010-04-15 |
University Of Chicago |
Compositions et procedes associes aux proteines bacteriennes eap, emp, et/ou adsa
|
BRPI0914522B1
(pt)
|
2008-10-30 |
2019-04-02 |
Evogene Ltd |
Método para aumentar o rendimento, a biomassa, a taxa de crescimento, o vigor, oteor de óleo, e/ou a eficiência da utilização do nitrogênio de uma planta
|
WO2010055525A1
(fr)
|
2008-11-17 |
2010-05-20 |
Technion Research & Development Foundation Ltd. |
Procédé pour prédire la réactivité d'un patient à une thérapie par antifolate
|
WO2010058396A1
(fr)
|
2008-11-19 |
2010-05-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Anticorps anti-cd44vra et procédés diagnostiques et thérapeutiques l'utilisant
|
WO2010061383A1
(fr)
|
2008-11-26 |
2010-06-03 |
Biodalia Microbiological Technologies Ltd. |
Procédé permettant d’enrichir in-situ des aliments avec des fructanes
|
WO2010064231A1
(fr)
|
2008-12-02 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Procédés d’analyse d’édition d’arn a-i et constructions d’acide nucléique capables de ceux-ci
|
US20120014927A1
(en)
|
2008-12-03 |
2012-01-19 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for determining predisposition to cancer
|
US8734759B2
(en)
|
2008-12-05 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing and treating motor neuron diseases
|
WO2010071610A1
(fr)
|
2008-12-19 |
2010-06-24 |
Agency For Science, Technology And Research (A*Star) |
Marqueurs biologiques de chikungunya sévère
|
WO2010076756A2
(fr)
|
2008-12-29 |
2010-07-08 |
Evogene Ltd. |
Polynucleotides, polypeptides codes par ceux-ci, et leurs procedes d'utilisation pour augmenter la tolerance au stress abiotique, la biomasse et/ou le rendement dans les plantes les exprimant
|
SG10201504379VA
(en)
|
2008-12-29 |
2015-07-30 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
EP2808402A3
(fr)
|
2008-12-29 |
2015-03-25 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Méthodes de prédiction de la réponse au traitement par interférons
|
US8455263B2
(en)
|
2008-12-30 |
2013-06-04 |
Jin Po Lee |
Quantitative analyte assay device and method
|
WO2010076794A1
(fr)
|
2008-12-31 |
2010-07-08 |
Technion Research & Development Foundation Ltd. |
Procédé pour dénitrifier une saumure et systèmes aptes à une telle dénitrification
|
US9107935B2
(en)
*
|
2009-01-06 |
2015-08-18 |
Gilead Biologics, Inc. |
Chemotherapeutic methods and compositions
|
IL196820A0
(en)
|
2009-02-01 |
2009-11-18 |
Yissum Res Dev Co |
Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
|
CN102369015A
(zh)
|
2009-02-02 |
2012-03-07 |
雷蒙特亚特特拉维夫大学有限公司 |
肽、包含该肽的药物组合物及其用途
|
WO2010089707A1
(fr)
|
2009-02-04 |
2010-08-12 |
Yeda Research And Development Co. Ltd. |
Procédé et trousses pour déterminer la sensibilité ou la résistance d'un cancer prostatique à une radiothérapie
|
EP2401362B1
(fr)
|
2009-02-26 |
2017-04-12 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Populations isolées de cellules souches rénales et leurs procédés d'isolement et d'utilisation
|
EP3460062B1
(fr)
|
2009-03-02 |
2021-05-05 |
Evogene Ltd. |
Polynucléotides et polypeptides isolés, et procédés d'utilisation de ceux-ci pour augmenter un rendement végétal et/ou des caractéristiques agricoles
|
HUE028729T2
(en)
|
2009-03-09 |
2017-01-30 |
Ramot At Tel-Aviv Univ Ltd |
Compositions for the prevention and treatment of neurodegenerative diseases
|
WO2010103517A1
(fr)
|
2009-03-12 |
2010-09-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions solubles pour le traitement de maladies associées aux ligands cxcr3
|
WO2010113096A1
(fr)
|
2009-03-30 |
2010-10-07 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Méthodes pour prévoir l'évolution clinique de la sclérose en plaque et la traiter
|
CN102448484A
(zh)
|
2009-04-01 |
2012-05-09 |
医学研究,基础设施和卫生服务基金的特拉维夫医疗中心 |
调节角质化细胞增生和分化的方法
|
EP2414387B1
(fr)
|
2009-04-03 |
2015-12-16 |
University Of Chicago |
Compositions et méthodes associées aux variants de la protéine a (spa)
|
WO2010116375A1
(fr)
|
2009-04-08 |
2010-10-14 |
Yeda Research And Development Co. Ltd. |
Peptides isolés pour réguler l'apoptose
|
PL2424896T3
(pl)
|
2009-04-30 |
2016-03-31 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Przeciwciała anty-ceacam1 oraz sposoby ich stosowania
|
EP2433136B1
(fr)
|
2009-05-19 |
2015-08-26 |
Zetiq Technologies Ltd. |
Kits et procédés pour coloration différentielle de cellules et/ou tissus cancéreux du col de l'utérus
|
US8980546B2
(en)
|
2009-05-21 |
2015-03-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Method for the detection of HIV-1-specific antibodies utilizing a Vpu polypeptide
|
CN102639146A
(zh)
|
2009-05-27 |
2012-08-15 |
耶达研究及发展有限公司 |
蛋白酶体抑制剂及其用途
|
WO2010137013A1
(fr)
|
2009-05-27 |
2010-12-02 |
Ramot At Tel Aviv University Ltd. |
Unités cristallisées de photosystème i dérivées du pois et leur utilisation dans des dispositifs solides
|
US20120078163A1
(en)
|
2009-05-27 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of generating connective tissue
|
US20120070449A1
(en)
|
2009-05-28 |
2012-03-22 |
Yeda Research And Development Co. Ltd. |
Methods of treating inflammation
|
MX363447B
(es)
|
2009-06-10 |
2019-03-22 |
Evogene Ltd |
Polinucleotidos y polipeptidos aislados, y metodos para utilizarlos para mejorar la eficacia en el uso de nitrogeno, rendimiento, tasa de crecimiento, vigor, biomasa, contenido de aceite y/o tolerancia al estres abiotico.
|
WO2010150259A1
(fr)
|
2009-06-24 |
2010-12-29 |
Fund For Medical Research Development Of Infrastructure And Health Services -Rambam Medical Center |
Méthodes et kits d'isolement de microparticules placentaires et utilisation dans le diagnostic des affections placentaires
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
WO2011004379A1
(fr)
|
2009-07-10 |
2011-01-13 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Compositions et méthodes de traitement du cancer
|
ES2753986T3
(es)
|
2009-07-21 |
2020-04-15 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Un método de diagnóstico de cáncer
|
GB0913442D0
(en)
|
2009-07-31 |
2009-09-16 |
Univ Ramot |
Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
|
WO2011021194A2
(fr)
|
2009-08-17 |
2011-02-24 |
Technion Research & Development Foundation Ltd. |
Cellules progénitrices de péricyte et leurs procédés de génération et d'utilisation
|
CA2771630A1
(fr)
*
|
2009-08-21 |
2011-02-24 |
Victoria Smith |
Procedes therapeutiques et compositions afferentes
|
US20110044907A1
(en)
*
|
2009-08-21 |
2011-02-24 |
Derek Marshall |
In vivo screening assays
|
CN102712683B
(zh)
|
2009-08-21 |
2014-09-10 |
吉联亚生物科技有限公司 |
赖氨酰氧化酶和loxl2的催化结构域
|
US20110207144A1
(en)
*
|
2009-08-21 |
2011-08-25 |
Derek Marshall |
In vitro screening assays
|
AU2010286111A1
(en)
|
2009-08-21 |
2012-02-16 |
Beeologics Inc. |
Preventing and curing beneficial insect diseases via plant transcribed molecules
|
US20110044981A1
(en)
*
|
2009-08-21 |
2011-02-24 |
Spangler Rhyannon |
Methods and compositions for treatment of pulmonary fibrotic disorders
|
US9642817B2
(en)
|
2009-08-27 |
2017-05-09 |
Technion Research & Development Foundation Limited |
Liposomal compositions and uses of same
|
WO2011030332A2
(fr)
|
2009-09-08 |
2011-03-17 |
Yeda Research And Development Co. Ltd. |
Procédés pour la mobilisation de précurseur hématopoïétique
|
WO2011030336A1
(fr)
|
2009-09-08 |
2011-03-17 |
Ramot At Tel-Aviv University Ltd. |
Procédés de diagnostic de la sclérose latérale amyotrophique (sla)
|
US20120171213A1
(en)
|
2009-09-10 |
2012-07-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating tumors
|
CN102498127B
(zh)
|
2009-09-17 |
2015-02-25 |
雷蒙特亚特特拉维夫大学有限公司 |
用于治疗氧化应激相关障碍的肽类
|
EP2478093A2
(fr)
|
2009-09-17 |
2012-07-25 |
Yeda Research and Development Co. Ltd. |
Polypeptides pon1 isolés, polynucléotides codant pour ceux-ci et utilisations de ceux-ci dans le traitement ou la prévention des dommages associés à l'exposition à un organophosphate
|
US8735124B2
(en)
|
2009-09-17 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
US20110081706A1
(en)
*
|
2009-10-02 |
2011-04-07 |
TransAlgae Ltd |
Method and system for efficient harvesting of microalgae and cyanobacteria
|
US8962584B2
(en)
|
2009-10-14 |
2015-02-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Compositions for controlling Varroa mites in bees
|
EP2488646B1
(fr)
|
2009-10-14 |
2017-12-06 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Compositions pour lutter contre les acariens varroa chez l'abeille
|
CA2777663A1
(fr)
|
2009-10-16 |
2011-04-21 |
University Of Medicine And Dentistry Of New Jersey |
Procede de traitement d'une lesion chronique du tissu nerveux a l'aide d'une strategie de therapie de cellules
|
WO2011048600A1
(fr)
|
2009-10-21 |
2011-04-28 |
Danziger Innovations Ltd. |
Génération de variations génotypiques dans des génomes de plantes par infection d'un gamète
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
|
US9018010B2
(en)
|
2009-11-12 |
2015-04-28 |
Technion Research & Development Foundation Limited |
Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
|
WO2011058555A1
(fr)
|
2009-11-12 |
2011-05-19 |
Yeda Research And Development Co. Ltd. |
Procédé d'édition de l'adn dans une cellule et constructions ayant cette capacité
|
US8962561B2
(en)
|
2009-11-12 |
2015-02-24 |
Ramot At Tel-Aviv University Ltd. |
Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes
|
US20120230974A1
(en)
|
2009-11-17 |
2012-09-13 |
Protalix Ltd |
Alkaline alpha galactosidase for the treatment of fabry disease
|
WO2011063198A2
(fr)
|
2009-11-20 |
2011-05-26 |
St. Jude Children's Research Hospital |
Procédés et compositions de modulation de l'activité du complexe du récepteur de l'interleukine 35
|
US20120273993A1
(en)
|
2009-11-24 |
2012-11-01 |
Collplant Ltd. |
Method of generating collagen fibers
|
IL288647B2
(en)
|
2009-11-30 |
2023-12-01 |
Pluri Biotech Ltd |
Adherent cells of placental origin and their use for the treatment of heart failure
|
US9562235B2
(en)
|
2009-12-06 |
2017-02-07 |
A.B. Seeds Ltd. |
MicroRNA compositions and methods for enhancing plant resistance to abiotic stress
|
WO2011072091A1
(fr)
|
2009-12-09 |
2011-06-16 |
Quark Pharmaceuticals, Inc. |
Méthodes et compositions utilisées pour le traitement de maladies, d'affections ou de lésions du snc
|
EP2519097B1
(fr)
|
2009-12-28 |
2016-03-02 |
Evogene Ltd. |
Polynucléotides isolés et polypeptides et procédés pour les utiliser afin d'augmenter le rendement des cultures, la biomasse, la vitesse de croissance, la vigueur, la teneur en huile, la tolérance au stress abiotique des plantes et l'efficacité d'utilisation de l'azote
|
ES2851601T3
(es)
|
2009-12-29 |
2021-09-08 |
Gamida Cell Ltd |
Métodos para mejorar la proliferación y actividad de los linfocitos citolíticos naturales
|
DK2521776T3
(en)
|
2010-01-05 |
2017-02-13 |
Vascular Biogenics Ltd |
METHODS FOR USING A SPECIFIC ANTI-ANGIOGENT ADENOVIRAL AGENT
|
SG182490A1
(en)
|
2010-01-12 |
2012-08-30 |
Vascular Biogenics Ltd |
Methods of producing adenovirus vectors and viral preparations generated thereby
|
CN102822202B
(zh)
|
2010-01-27 |
2015-07-22 |
耶达研究及发展有限公司 |
抑制金属蛋白的抗体
|
CN105622757A
(zh)
|
2010-02-04 |
2016-06-01 |
吉联亚生物科技有限公司 |
结合赖氨酰氧化酶样2(loxl2)的抗体和其使用方法
|
US9410131B2
(en)
|
2010-02-11 |
2016-08-09 |
Yeda Research And Development Co. Ltd. |
Enzymatic systems for carbon fixation and methods of generating same
|
US10080799B2
(en)
|
2010-02-12 |
2018-09-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods and compositions related to glycoprotein-immunoglobulin fusions
|
US20130109615A1
(en)
|
2010-02-24 |
2013-05-02 |
Ben Gurion University Of The Negev Research And Development Authority |
Methods for inhibiting necrosis
|
WO2011107939A1
(fr)
|
2010-03-01 |
2011-09-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthodes de prédiction de l'efficacité d'un traitement par anti-vegfa pour des tumeurs solides
|
WO2011107994A1
(fr)
|
2010-03-04 |
2011-09-09 |
Yeda Research And Development Co. Ltd. |
Procédés de mesure de la stabilité d'une protéine
|
EP2545176B1
(fr)
|
2010-03-08 |
2016-05-11 |
Yeda Research and Development Co. Ltd. |
Production de protéines recombinantes dans des systèmes hétérologues
|
MX2012010479A
(es)
|
2010-03-08 |
2012-10-09 |
Monsanto Technology Llc |
Moleculas polinucleotidicas para regulacion genetica en plantas.
|
CN102918159A
(zh)
|
2010-03-11 |
2013-02-06 |
雅各布·埃德尔 |
产生氢的方法
|
WO2011125015A2
(fr)
|
2010-04-05 |
2011-10-13 |
Bar-Ilan University |
Polypeptides formant des pores pouvant être activés par une protéase
|
US8808699B2
(en)
|
2010-04-05 |
2014-08-19 |
The University Of Chicago |
Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response
|
US9458438B2
(en)
|
2010-04-12 |
2016-10-04 |
Ben Gurion University Of The Negev Research And Development Authority |
Sulfotransferase of a red microalga and uses thereof
|
US8927274B2
(en)
|
2010-04-12 |
2015-01-06 |
Technion Research & Development Foundation Limited |
Populations of pancreatic progenitor cells and methods of isolating and using same
|
CA2792826A1
(fr)
|
2010-04-18 |
2011-10-27 |
Yeda Research And Development Co. Ltd. |
Molecules et methodes d'utilisation de celles-ci pour le traitement des maladies associees aux ligands erbb/erbb
|
AU2011246876B2
(en)
|
2010-04-28 |
2016-06-23 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
|
US20130053277A1
(en)
|
2010-05-04 |
2013-02-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of identifying inhibitors of polypeptides-of-interest
|
US9352000B2
(en)
|
2010-05-05 |
2016-05-31 |
Rappaport Family Institute For Research In The Medical Sciences |
Use of CCL1 in therapy
|
IL208820A0
(en)
|
2010-10-19 |
2011-01-31 |
Rachel Teitelbaum |
Biologic female contraceptives
|
US20130059325A1
(en)
|
2010-05-13 |
2013-03-07 |
Tel HaShomer Medical Research Infratructure and Services Ltd. |
Isolated populations of adult renal cells and methods of isolating and using same
|
CN103037891A
(zh)
|
2010-06-03 |
2013-04-10 |
雷蒙特亚特特拉维夫大学有限公司 |
治疗糖尿病的方法和能够治疗糖尿病的组合物
|
JP2013529092A
(ja)
|
2010-06-07 |
2013-07-18 |
− ファビアン、オスナット アシュル |
低酸素症に関連する状態を診断する方法およびキット
|
WO2011158243A2
(fr)
|
2010-06-16 |
2011-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé de diagnostic et de traitement du cancer
|
WO2011158242A2
(fr)
|
2010-06-16 |
2011-12-22 |
Futuragene Israel Ltd. |
Plantes résistantes aux organismes nuisibles
|
CN103037885B
(zh)
|
2010-07-02 |
2015-08-26 |
芝加哥大学 |
与蛋白A(SpA)变体相关的组合物和方法
|
WO2012007945A2
(fr)
|
2010-07-12 |
2012-01-19 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center |
Polynucléotides isolés et procédés et plantes les utilisant pour la régulation de l'acidité des plantes
|
CA2805479A1
(fr)
|
2010-07-15 |
2012-01-19 |
Technion Research & Development Foundation Ltd. |
Entites isolees a affinite elevee dotees d'une specificite telle que celle des recepteurs de lymphocytes t pour des complexes natifs du cmh de classe ii et peptides auto-antigenes de la decarboxylase de l'acide glutamique (gad)
|
CA2804728A1
(fr)
|
2010-07-15 |
2012-01-19 |
Technion Research & Development Foundation Ltd. |
Construction d'acide nucleique destinee a accroitre la tolerance au stress abiotique dans des vegetaux
|
EP2593480A2
(fr)
|
2010-07-15 |
2013-05-22 |
Technion Research & Development Foundation Ltd. |
Entités de haute affinité isolées présentant une spécificité de type récepteur des lymphocytes t pour les complexes natifs du mhc de classe ii et les peptides auto-antigéniques associés au diabète
|
US9624469B2
(en)
|
2010-07-22 |
2017-04-18 |
Cellect Biotherapeutics Ltd. |
Regulatory immune cells with enhanced targeted cell death effect
|
WO2012014205A1
(fr)
|
2010-07-27 |
2012-02-02 |
Technion Research & Development Foundation Ltd. |
Cellules progénitrices mésenchymateuses isolées et matrice extra-cellulaire produite au moyen de celles-ci
|
WO2012014207A2
(fr)
|
2010-07-27 |
2012-02-02 |
Technion Research & Development Foundation Ltd. |
Procédé de génération de cellules souches pluripotentes induites à partir de kératinocytes dérivés de follicules pileux prélevés
|
US20130130311A1
(en)
|
2010-07-27 |
2013-05-23 |
Yeda Research And Development Co., Ltd. |
Methods and systems for assessing clonality of cell cultures
|
EP2600885A2
(fr)
|
2010-08-04 |
2013-06-12 |
Ramot at Tel Aviv University, Ltd. |
Procédés de traitement de maladies auto-immunes du système nerveux central (snc) et de maladies neurodégénératives
|
SG187830A1
(en)
|
2010-08-22 |
2013-03-28 |
Univ Ramot |
Induced pluripotent stem cells derived from human pancreatic beta cells
|
WO2012025925A1
(fr)
|
2010-08-24 |
2012-03-01 |
Rappaport Family Institute For Research In The Medical Sciences |
Procédés d'amélioration de la transplantation en utilisant des sdf-1alpha
|
MX2018009863A
(es)
|
2010-08-30 |
2022-06-14 |
Evogene Ltd |
Polinucleotidos y polipeptidos aislados, y metodos para utilizarlos para aumentar la eficacia en el uso de nitrogeno, rendimiento, tasa de crecimiento, vigor, biomasa, contenido de aceite y/o tolerancia al estres abiotico.
|
WO2012032520A1
(fr)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Translecture d'acétylcholinestérase (ache-r) pour le traitement ou la prévention de la maladie de parkinson
|
WO2012032510A1
(fr)
|
2010-09-07 |
2012-03-15 |
Yeda Research And Development Co. Ltd. |
Amorces pour l'amplification d'adn et procédés de sélection de ces dernières
|
WO2012032519A2
(fr)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthodes de diagnostic de la maladie de parkinson
|
ES2746482T3
(es)
|
2010-09-07 |
2020-03-06 |
Technion Res & Dev Foundation |
Nuevos métodos y medios de cultivo para cultivar células madre pluripotentes
|
EP2613801B1
(fr)
|
2010-09-08 |
2016-06-08 |
Yeda Research and Development Co. Ltd. |
LYMPHOCYTES T À MÉMOIRE CENTRALE ANTI-TIERS, ET UTILISATION DE CEUX-CI DANS UN TRAITEMENT & xA;'ANTI-LEUKEMIA/LYMPHOMA'
|
SG188471A1
(en)
|
2010-09-08 |
2013-04-30 |
Yeda Res & Dev |
An immunosuppressive drug combination for a stable and long term engraftment
|
EP2614074A1
(fr)
|
2010-09-09 |
2013-07-17 |
The University of Chicago |
Procédés et compositions impliquant des antigènes staphylococciques protecteurs
|
CN103210082A
(zh)
|
2010-09-15 |
2013-07-17 |
雷蒙特亚特特拉维夫大学有限公司 |
扩增胰岛β细胞和使其再分化的方法
|
US20130210901A1
(en)
|
2010-09-20 |
2013-08-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating neurodegenerative diseases
|
EP2627766B1
(fr)
|
2010-10-17 |
2016-05-25 |
Yeda Research and Development Co. Ltd. |
Procédés et compositions utilisables en vue du traitement de pathologies médicales associées à l'insuline
|
WO2012052878A1
(fr)
|
2010-10-19 |
2012-04-26 |
Vascular Biogenics Ltd. |
Polynucléotides isolés et constructions d'acide nucléique pour diriger l'expression d'un gène d'intérêt dans des cellules
|
WO2012056452A2
(fr)
|
2010-10-27 |
2012-05-03 |
Nanocyte (Israel) Ltd. |
Compositions pharmaceutiques et dispositifs d'administration comprenant des cellules ou capsules urticantes
|
WO2012056455A1
(fr)
|
2010-10-28 |
2012-05-03 |
Yeda Research And Development Co. Ltd. |
Procédés de génération d'anticorps anti-métalloenzymes
|
CN103237895A
(zh)
|
2010-11-03 |
2013-08-07 |
耶路撒冷希伯来大学伊森姆研究发展有限公司 |
具有提高的糖化产率的转基因植物以及产生其的方法
|
US9410132B2
(en)
|
2010-11-04 |
2016-08-09 |
Ben-Gurion University Of The Negev Research And Development Authority |
Acyl-CoA: diacylglycerol acyltransferase 1-like gene (PtDGAT1) and uses thereof
|
MX2013005413A
(es)
|
2010-11-15 |
2014-02-27 |
Univ Ramot |
Analogos de dipeptidos para el tratamiento de afecciones asociadas con la formacion de fibrillas amiloides.
|
WO2012066495A2
(fr)
|
2010-11-17 |
2012-05-24 |
Ben Gurion University Of The Negev Research And Development Authority |
Thérapie à base de cellules t pour les maladies neurodégénératives
|
WO2012075111A1
(fr)
|
2010-11-30 |
2012-06-07 |
Novartis Ag |
Utilisation d'anticorps anti-cd40 en thérapie combinée contre des cancers associés aux cellules b
|
US9574171B2
(en)
|
2010-12-02 |
2017-02-21 |
Technion Research & Development Foundation Ltd. |
Methods of generating corneal cells and cell populations comprising same
|
US20120183960A1
(en)
|
2010-12-07 |
2012-07-19 |
Enterologics, Inc. |
Method for identifying e. coli m-17
|
WO2012081029A1
(fr)
|
2010-12-15 |
2012-06-21 |
Kadimastem Ltd. |
Cellules produisant de l'insuline dérivées de cellules souches pluripotentes
|
BR122020018456B1
(pt)
|
2010-12-22 |
2021-10-19 |
Evogene Ltd. |
Método para aumentar a tolerância ao estresse abiótico, rendimento, biomassa, taxa de crescimento, vigor, e/ou eficiência de uso de nitrogênio de uma planta, e, construto de ácido nucleico isolado
|
BR112013016535A2
(pt)
|
2010-12-28 |
2016-09-20 |
Bio Fd&C Co Ltd |
extratos vegetais para o tratamento e prevenção de infecções
|
PT3272861T
(pt)
|
2011-01-20 |
2020-03-26 |
Protalix Ltd |
Construção de ácido nucleico para expressão de alfα-galactosidase em plantas e células de plantas
|
US20130316358A1
(en)
|
2011-01-31 |
2013-11-28 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing disease using overlap extension pcr
|
WO2012114339A1
(fr)
|
2011-02-23 |
2012-08-30 |
Rappaport Family Institute For Research In The Medical Sciences |
Molécules de haute affinité capables de se lier à un récepteur plexine de type a et leurs utilisations
|
EP2492279A1
(fr)
|
2011-02-25 |
2012-08-29 |
Laboratorios Del. Dr. Esteve, S.A. |
Procédé de sélection rapide d'immunogène par expression à la surface du lentivirus.
|
WO2012117406A2
(fr)
|
2011-03-02 |
2012-09-07 |
Futuragene Israel Ltd. |
Plantes transgéniques résistantes aux bactéries
|
EP2680864B1
(fr)
|
2011-03-03 |
2019-05-08 |
Ramot at Tel-Aviv University Ltd. |
Cellules musculaires génétiquement modifiées qui expriment des facteurs neurotrophiques
|
US9574003B2
(en)
|
2011-03-06 |
2017-02-21 |
Merck Serono S.A. |
Low fucose cell lines and uses thereof
|
US9061006B2
(en)
|
2011-03-08 |
2015-06-23 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for diagnosing and treating phenylketonuria (PKU)
|
IN2013MN01438A
(fr)
|
2011-03-17 |
2015-06-12 |
Univ Ramot |
|
WO2012123938A1
(fr)
|
2011-03-17 |
2012-09-20 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Analogues de quinolone pour le traitement de maladies auto-immunes
|
WO2012127320A1
(fr)
|
2011-03-22 |
2012-09-27 |
Pluristem Ltd. |
Procédés de traitement de blessures dues aux expositions aux irradiations ou aux produits chimiques
|
BR112013024323A2
(pt)
|
2011-03-24 |
2017-06-13 |
Neurim Pharmaceuticals ( 1991 ) Ltd |
peptídeos neuroprotetores
|
WO2012131680A2
(fr)
|
2011-03-28 |
2012-10-04 |
Yeda Research And Development Co. Ltd. |
Compositions et procédés pour le traitement de l'inflammation
|
WO2012137202A1
(fr)
|
2011-04-05 |
2012-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Composition comprenant un indicateur de fer attaché à une microparticule et utilisations de celle-ci pour quantifier du fer non lié à la transferrine (ntbi) et du fer labile cellulaire (lci)
|
AU2012240953B2
(en)
|
2011-04-06 |
2017-02-23 |
Ramot At Tel-Aviv University Ltd. |
Methods of monitoring and analyzing metabolic activity profiles diagnostic and therapeutic uses of same
|
US9150644B2
(en)
|
2011-04-12 |
2015-10-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
|
CA2832812C
(fr)
|
2011-04-15 |
2017-12-05 |
Pluristem Ltd. |
Procedes et systemes de recolte de cellules
|
MX354195B
(es)
|
2011-05-03 |
2018-02-16 |
Evogene Ltd |
Polipeptidos y polinucleotidos aislados y metodos para su uso, para aumentar el rendimiento, la biomasa, el indice de crecimiento, el vigor, el contenido de aceite, la tolerancia al estrés abiotico de las plantas y la eficiencia en el uso de nitrogeno.
|
WO2012150600A2
(fr)
|
2011-05-04 |
2012-11-08 |
Ramot At Tel-Aviv University Ltd. |
Régulation de la composition moléculaire des bêta amyloïdes pour le traitement de la maladie d'azheimer
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
WO2012153333A1
(fr)
|
2011-05-09 |
2012-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Régénération et réparation de tissu mésenchymateux par utilisation d'amélogénine
|
WO2012153336A2
(fr)
|
2011-05-12 |
2012-11-15 |
Rakuto Bio Technologies Ltd. |
Procédés et dispositifs pour éclaircir la carnation de la peau
|
WO2012156976A1
(fr)
|
2011-05-16 |
2012-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés de préparation d'artémisinine dans des plantes non-hôtes et vecteurs destinés à une utilisation dans celles-ci
|
WO2012160526A2
(fr)
|
2011-05-23 |
2012-11-29 |
Ofir Menashe |
Formulations à base de particules contenant des micro-organismes et leurs utilisations
|
US20140088017A1
(en)
|
2011-05-23 |
2014-03-27 |
Yeda Research And Development Co., Ltd. |
Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
|
KR101920541B1
(ko)
|
2011-05-31 |
2018-11-20 |
허치슨 바이오필름 메디컬 솔루션스 리미티드 |
세포 응집물의 분산 및 분리
|
WO2012164565A1
(fr)
|
2011-06-01 |
2012-12-06 |
Yeda Research And Development Co. Ltd. |
Compositions et procédés pour la régulation à la baisse de gènes procaryotes
|
US10166295B2
(en)
|
2011-06-02 |
2019-01-01 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
EP2720720B1
(fr)
|
2011-06-14 |
2018-02-28 |
Yeda Research and Development Co. Ltd. |
Plurithérapie destinée à empêcher la formation de dcis et l'évolution en un cancer du sein
|
MX2014000180A
(es)
|
2011-06-23 |
2014-03-27 |
Kaiima Bio Agritech Ltd |
Trigo comun, sus plantas o partes que tienen un genoma parcial o completamente multiplicado, sus hibridos y productos y metodos para generarlos y utilizarlos.
|
US9587010B2
(en)
|
2011-07-18 |
2017-03-07 |
The Institute For Research In Biomedicine |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
KR20140062468A
(ko)
|
2011-07-20 |
2014-05-23 |
카이마 바이오 아그리테크 리미티드 |
부분적으로 또는 완전히 다배수화된 게놈을 갖는 옥수수 식물체 및 이의 용도
|
US20130030452A1
(en)
|
2011-07-27 |
2013-01-31 |
Health Corporation - Rambam |
Devices for surgical applications
|
CA2844012C
(fr)
|
2011-08-04 |
2021-03-16 |
Yeda Research And Development Co. Ltd. |
Micro-arn et compositions les comprenant pour le traitement et le diagnostic de troubles medicaux associes a la serotonine, a l'adrenaline, a la noradrenaline, au glutamate et a l'hormone de liberation de la corticotropine
|
US9499793B2
(en)
|
2011-08-09 |
2016-11-22 |
Yeda Research And Development Co. Ltd. |
Downregulation of miR-7 for promotion of beta cell differentiation and insulin production
|
MX2014001777A
(es)
|
2011-08-14 |
2014-08-21 |
Kaiima Bio Agritech Ltd |
Plantas de trigo durum que tienen un genoma parcial completamente multiplicado y sus usos.
|
US9959392B2
(en)
|
2011-09-07 |
2018-05-01 |
Yeda Research And Development Co. Ltd. |
Olfactory signature and odorant mixture having the same
|
EP2753716B1
(fr)
|
2011-09-08 |
2017-11-01 |
Yeda Research and Development Co. Ltd. |
Nouveaux biomarqueurs de risque pour le cancer du poumon
|
JP6196620B2
(ja)
|
2011-09-08 |
2017-09-13 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
抗第三者セントラルメモリーt細胞、その作製方法ならびに移植および疾患処置におけるその使用
|
US10806146B2
(en)
|
2011-09-13 |
2020-10-20 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
CN110066794A
(zh)
|
2011-09-13 |
2019-07-30 |
孟山都技术公司 |
用于杂草控制的方法和组合物
|
US10760086B2
(en)
|
2011-09-13 |
2020-09-01 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10829828B2
(en)
|
2011-09-13 |
2020-11-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
CN107739737A
(zh)
|
2011-09-13 |
2018-02-27 |
孟山都技术公司 |
用于杂草控制的方法和组合物
|
UA116093C2
(uk)
|
2011-09-13 |
2018-02-12 |
Монсанто Текнолоджи Ллс |
Спосіб та композиція для боротьби з бур'янами (варіанти)
|
UA116090C2
(uk)
|
2011-09-13 |
2018-02-12 |
Монсанто Текнолоджи Ллс |
Спосіб та композиція для боротьби з бур'янами (варіанти)
|
WO2013054320A1
(fr)
|
2011-10-11 |
2013-04-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Anticorps dirigés contre la molécule d'adhésion cellulaire associée à l'antigène carcino-embryonnaire (ceacam)
|
BR112014009536A2
(pt)
|
2011-10-21 |
2017-04-18 |
Augurex Life Sciences Corp |
antígenos derivados de 14-3-3 xitrulinada e usos dos mesmos no diagnóstico de artrite reumatoide
|
US9145559B2
(en)
|
2011-10-27 |
2015-09-29 |
Yeda Research And Development Co. Ltd. |
Methods of treating cancer
|
MX356814B
(es)
|
2011-11-03 |
2018-06-13 |
Quark Pharmaceuticals Inc |
Métodos y composiciones para neuroprotección.
|
WO2013070821A1
(fr)
|
2011-11-08 |
2013-05-16 |
Quark Pharmaceuticals, Inc. |
Méthodes et compositions destinées à traiter des maladies, des troubles ou une lésion du système nerveux
|
WO2013076729A1
(fr)
|
2011-11-23 |
2013-05-30 |
Danziger Dan Flower Farm |
Plantes de type otomeria
|
US9617331B2
(en)
|
2011-11-27 |
2017-04-11 |
Yeda Research And Development Co. Ltd. |
Methods of regulating angiogenesis by administering agents which increase apoB-100 polypeptide
|
CN104105493A
(zh)
|
2011-12-08 |
2014-10-15 |
耶达研究及发展有限公司 |
哺乳动物胎儿肺细胞以及其治疗用途
|
WO2013093921A1
(fr)
|
2011-12-20 |
2013-06-27 |
Collplant Ltd. |
Fibres de polymère synthétique enrobées de collagène
|
CN104254395B
(zh)
|
2011-12-22 |
2016-05-04 |
生命科技公司 |
用于分析物测定的序贯侧向流动毛细管装置
|
RU2657758C2
(ru)
|
2011-12-22 |
2018-06-15 |
Иеда Рисеч Энд Девелопмент Ко. Лтд. |
Комбинированная терапия для стабильного и долговременного приживления трансплантата
|
EP2797405A1
(fr)
|
2011-12-28 |
2014-11-05 |
Kaiima Bio Agritech Ltd. |
Sorgho agricole à génome partiellement ou complètement multiplié, et utilisations correspondantes
|
SG11201403756PA
(en)
|
2012-01-01 |
2014-11-27 |
Qbi Entpr Ltd |
Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
|
WO2013114363A2
(fr)
|
2012-01-30 |
2013-08-08 |
Yeda Research And Development Co.Ltd. |
Agents antimicrobiens
|
US9603907B2
(en)
|
2012-02-01 |
2017-03-28 |
Protalix Ltd. |
Dry powder formulations of dNase I
|
US10184131B2
(en)
|
2012-02-06 |
2019-01-22 |
A.B. Seeds Ltd. |
Isolated polynucleotides expressing or modulating microRNAs or targets of same, transgenic plants comprising same and uses thereof
|
US10047345B2
(en)
|
2012-02-13 |
2018-08-14 |
Gamida-Cell Ltd. |
Culturing of mesenchymal stem cells with FGF4 and nicotinamide
|
KR102118729B1
(ko)
|
2012-02-14 |
2020-06-05 |
옵코 바이오로직스 리미티드 |
장기 작용 응고 인자들 및 이를 생산하는 방법들
|
EP2814838A1
(fr)
|
2012-02-19 |
2014-12-24 |
Protalix Ltd. |
Formes galéniques unitaires administrées par voie orale et utilisations de celles-ci pour le traitement de la maladie de gaucher
|
US10034902B2
(en)
|
2012-02-22 |
2018-07-31 |
Exostem Biotec Ltd. |
MicroRNAs for the generation of astrocytes
|
WO2013124816A2
(fr)
|
2012-02-22 |
2013-08-29 |
Brainstem Biotec Ltd. |
Génération de cellules souches neuronales et de motoneurones
|
US20150101074A1
(en)
|
2012-03-01 |
2015-04-09 |
The State of Israel, Ministry of Agriculture & Rural Development, Agriculture Research |
Male sterile garlic plants, hybrid offspring of same and methods of generating and using same
|
WO2013132495A1
(fr)
|
2012-03-07 |
2013-09-12 |
Yeda Research And Development Co. Ltd. |
Compositions inhibitrices de la quiescine sulfhydryle oxydase (qsox1) et leurs utilisations
|
EP2828293B1
(fr)
|
2012-03-20 |
2017-10-25 |
Humabs Biomed S.A. |
Anticorps qui neutralisent rsv, mpv et pvm et leurs utilisations
|
EP2828280B1
(fr)
|
2012-03-22 |
2018-05-02 |
Ramot at Tel-Aviv University Ltd. |
Peptides multimères plif et utilisations de ceux-ci
|
US9283272B2
(en)
|
2012-03-30 |
2016-03-15 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Targeting intracellular target-binding determinants with intracellular antibodies
|
JP2015514746A
(ja)
|
2012-04-18 |
2015-05-21 |
ラモット アット テル アビブ ユニバーシティ, リミテッド |
核酸を送達するための脂質化グリコサミノグリカン粒子
|
EP2838552A4
(fr)
|
2012-04-19 |
2016-05-18 |
Opko Biolog Ltd |
Variants d'oxyntomoduline à action prolongée et procédés pour les produire
|
EP2841084B1
(fr)
|
2012-04-24 |
2018-05-30 |
Biokine Therapeutics Ltd. |
Peptide antagoniste de cxcr4 et son utilisation pour le traitment de tumeurs pulmonaires
|
NZ702285A
(en)
|
2012-04-26 |
2016-07-29 |
Univ Chicago |
Staphylococcal coagulase antigens and methods of their use
|
WO2013168164A1
(fr)
|
2012-05-09 |
2013-11-14 |
Yeda Research And Development Co. Ltd. |
VARIANTS DE PRO-DOMAINE TACE EN TANT QU'INHIBITEUR DE TNF-α ET LEUR UTILISATION MÉDICALE
|
US8865158B2
(en)
|
2012-05-22 |
2014-10-21 |
Ramot At Tel-Aviv University Ltd. |
Bacteriophages for reducing toxicity of bacteria
|
MX360866B
(es)
|
2012-05-24 |
2018-11-09 |
A B Seeds Ltd |
Composiciones y métodos para silenciar la expresión genética.
|
US9290564B2
(en)
|
2012-05-24 |
2016-03-22 |
Mountgate Group Limited |
Compositions and methods related to the prevention and treatment of rabies infection
|
EP2855507B1
(fr)
|
2012-06-03 |
2018-01-03 |
Ben-Gurion University of The Negev Research and Development Authority |
Peptides de liaison au titane fonctionnalisés et implants revêtus par ceux-ci
|
US10537646B2
(en)
|
2012-06-04 |
2020-01-21 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
US10023474B2
(en)
|
2012-07-03 |
2018-07-17 |
Nanospun Technologies Ltd. |
Methods for adsorption and biodegradation of petroleum
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
US10155933B2
(en)
|
2012-07-29 |
2018-12-18 |
Yeda Research And Development Co., Ltd. |
Use of the reductive glycine pathway for generating formatotrophic and autotrophic microorganisms
|
EP2879678B1
(fr)
|
2012-07-31 |
2023-03-01 |
Yeda Research and Development Co. Ltd. |
Enoxacin pour le traitement de la sclérose latérale amyotrophique
|
ES2813407T3
(es)
|
2012-08-06 |
2021-03-23 |
Brainstorm Cell Therapeutics Ltd |
Métodos para generar células madre mesenquimales que secretan factores neurotróficos
|
EP2698377A1
(fr)
|
2012-08-17 |
2014-02-19 |
Laboratorios Del. Dr. Esteve, S.A. |
Procédé de sélection rapide d'immunogène de variants de la GP-120 du VIH amélioré
|
AR092868A1
(es)
|
2012-09-03 |
2015-05-06 |
A B Seeds Ltd |
Metodo para mejorar la tolerancia al estres abiotico de plantas y plantas generadas mediante dicho metodo
|
WO2014041544A1
(fr)
|
2012-09-12 |
2014-03-20 |
Ramot At Tel-Aviv University Ltd. |
Immunoparticules et procédés pour les produire et les utiliser
|
US9701719B2
(en)
|
2012-09-27 |
2017-07-11 |
Research Development Foundation |
Attenuated Chikungunya virus
|
US11105809B2
(en)
|
2012-10-09 |
2021-08-31 |
Ramot At Tel-Aviv University Ltd. |
Methods and kits for predicting prognosis of cancer using soluble mortalin in blood
|
AU2013336237A1
(en)
|
2012-10-22 |
2015-06-11 |
Sabag-Rfa Ltd |
A system for delivering therapeutic agents into living cells and cells nuclei
|
WO2014064682A1
(fr)
|
2012-10-24 |
2014-05-01 |
Yeda Research And Development Co. Ltd. |
Combinaisons d'anticorps ciblant les récepteurs du facteur de croissance épidermique pour traiter le cancer
|
EP2912181B1
(fr)
|
2012-10-29 |
2017-11-29 |
Yeda Research and Development Co., Ltd. |
Aptamères, aptamères multimères et leurs utilisations
|
SG10202010383YA
(en)
|
2012-11-20 |
2020-11-27 |
Opko Biologics Ltd |
Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides
|
JP2016502536A
(ja)
|
2012-11-29 |
2016-01-28 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
腫瘍転移を防止し、がんを処置および予後診断し、推定転移阻害剤である薬剤を同定する方法
|
WO2015079413A2
(fr)
|
2013-11-28 |
2015-06-04 |
Yeda Research And Development Co. Ltd. |
Inhibiteurs de synaptojanine-2 et leurs utilisations
|
US10683505B2
(en)
|
2013-01-01 |
2020-06-16 |
Monsanto Technology Llc |
Methods of introducing dsRNA to plant seeds for modulating gene expression
|
UY35252A
(es)
|
2013-01-01 |
2014-07-31 |
Seeds Ltd Ab |
MÉTODOS PARA INTRODUCIR dsRNA EN SEMILLAS DE PLANTAS PARA MODULAR LA EXPRESIÓN GENÉTICA
|
WO2014108854A1
(fr)
|
2013-01-09 |
2014-07-17 |
Fusimab Ltd. |
Anticorps anti-hgf et anti-ang2 monospécifiques, et anticorps anti-hgf/anti-ang2 bispécifiques
|
WO2014108850A2
(fr)
|
2013-01-09 |
2014-07-17 |
Yeda Research And Development Co. Ltd. |
Analyse de transcriptome à haut débit
|
CA2894472C
(fr)
|
2013-01-17 |
2021-08-17 |
Novellusdx Ltd. |
Procedes et systemes pour identifier des mutations conductrices specifiques a un patient
|
US10000737B2
(en)
|
2013-02-04 |
2018-06-19 |
Ramot At Tel-Aviv University Ltd. |
Generation of cytotoxic tumor specific cell lines and uses thereof
|
BR112015021708A2
(pt)
|
2013-03-06 |
2017-08-29 |
Protalix Ltd |
Inibidor de polipetídeo do tnfa, polinucleotídeo isolado, estrutura de expressão de ácido nucleico, célula de planta, composição farmacêutica e método de produção de um inibidor de polipeptídeo do tnfa
|
CA2902727C
(fr)
|
2013-03-06 |
2020-08-18 |
Protalix Ltd. |
Utilisation de cellules vegetales exprimant un inhibiteur du polypeptide tnf alpha en therapie
|
US10358667B2
(en)
|
2013-03-07 |
2019-07-23 |
University Of Maryland, Baltimore |
Immunotherapeutic potential of modified lipooligosaccharides/lipid A
|
BR112015023051A2
(pt)
|
2013-03-13 |
2017-11-14 |
Monsanto Technology Llc |
método para controle de ervas daninhas, composição herbicida, cassete de expressão microbiano e método de produção de polinucleotídeo
|
BR112015022797A2
(pt)
|
2013-03-13 |
2017-11-07 |
Monsanto Technology Llc |
método para controle de ervas daninhas, composição herbicida, cassete de expressão microbiano e método de produção de polinucleotídeo
|
US10568328B2
(en)
|
2013-03-15 |
2020-02-25 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
EP2976097B1
(fr)
|
2013-03-21 |
2021-05-26 |
CollPlant Ltd. |
Compositions comprenant du collagène et prp pour la régénération tissulaire et leurs procédés de production
|
AU2014240733B2
(en)
|
2013-03-24 |
2018-11-22 |
Biolinerx Ltd. |
Methods of treating myeloid leukemia
|
JP2016516808A
(ja)
|
2013-04-21 |
2016-06-09 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
Bcl−xLおよび/またはBcl−wの活性および/または量を下方制御するための薬剤
|
US10920192B2
(en)
|
2013-04-23 |
2021-02-16 |
Yeda Research And Development Co. Ltd. |
Isolated naive pluripotent stem cells and methods of generating same
|
CN105555796B
(zh)
|
2013-04-25 |
2019-09-17 |
耶达研究及发展有限公司 |
抑制肽对治疗炎性疾病的用途
|
EP2999717B1
(fr)
|
2013-05-21 |
2018-08-08 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Traitement des pathologies impliquant des mastocytes
|
WO2014191995A2
(fr)
|
2013-05-27 |
2014-12-04 |
Rakuto Bio Technologies Ltd. |
Compositions cosmétiques contenant un système enzymatique
|
ES2938044T3
(es)
|
2013-06-24 |
2023-04-04 |
Univ Ramot |
Estructura a base de epiplón y sistema de suministro
|
US9850496B2
(en)
|
2013-07-19 |
2017-12-26 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
CN105980567B
(zh)
|
2013-07-19 |
2021-04-16 |
孟山都技术有限公司 |
用于控制叶甲属的组合物和方法
|
WO2015015489A1
(fr)
|
2013-07-30 |
2015-02-05 |
Biolinerx Ltd. |
Anticorps convenant au traitement du diabète et de maladies autoimmunes
|
WO2015029035A1
(fr)
|
2013-08-29 |
2015-03-05 |
Yeda Research And Development Co. Ltd. |
Inhibiteurs sélectifs de l'isoforme α2 de la na,k-atpase et leur utilisation pour réduire la pression intra-oculaire
|
IL228284A
(en)
|
2013-09-03 |
2016-12-29 |
Technion Res & Dev Foundation |
Implants from cellular scaffolding and blood vessel stalk
|
WO2015033343A1
(fr)
|
2013-09-03 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions et procédés utilisables en vue de l'expression de polypeptides recombinés
|
WO2015033344A1
(fr)
|
2013-09-05 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés et nécessaires permettant d'inhiber la pathogénicité d'un streptocoque du groupe a (sga) ou d'un streptocoque du groupe g (sgg)
|
WO2015037009A1
(fr)
|
2013-09-16 |
2015-03-19 |
Plexicure Ltd. |
Protéines isolées capables de se lier à la plexine-a4, et procédés de production et d'utilisation
|
EP3046929B1
(fr)
|
2013-09-17 |
2019-01-16 |
Yeda Research and Development Co., Ltd. |
Nouveaux peptides d'erk et leurs utilisations
|
JP6474795B2
(ja)
|
2013-10-01 |
2019-02-27 |
カディマステム リミテッド |
薬物スクリーニング及び筋萎縮性側索硬化症(als)の処置における使用のための、ヒト多能性幹細胞からのアストロサイトの指向性分化
|
RU2683498C2
(ru)
|
2013-10-02 |
2019-03-28 |
МЕДИММЬЮН, ЭлЭлСи |
Нейтрализующие антитела к вирусу гриппа а и пути их применения
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
MX2016005227A
(es)
|
2013-10-21 |
2016-08-12 |
Opko Biologics Ltd |
Polipéptidos de acción prolongada y métodos para su producción y administración.
|
WO2015059690A1
(fr)
|
2013-10-24 |
2015-04-30 |
Yeda Research And Development Co. Ltd. |
Polynucléotides codant pour des polypeptides de système brex et leurs méthodes d'utilisation
|
EP3062809B1
(fr)
|
2013-10-31 |
2020-07-08 |
Biokine Therapeutics Ltd. |
Un inhibiteur peptidique de cxcr4 pour le traitement de la leucémie myéloïde aiguë avec mutation de la flt3
|
CA2929533C
(fr)
|
2013-11-04 |
2023-06-06 |
Monsanto Technology Llc |
Compositions et procedes de lutte contre les infestations de parasites de type arthropode et d'organismes nuisibles
|
ES2754207T3
(es)
|
2013-11-28 |
2020-04-16 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Inhibidores de la ARN polimerasa I y usos de los mismos
|
UA119253C2
(uk)
|
2013-12-10 |
2019-05-27 |
Біолоджикс, Інк. |
Спосіб боротьби із вірусом у кліща varroa та у бджіл
|
DK3080243T3
(en)
|
2013-12-10 |
2019-01-07 |
Yeda Res & Dev |
USE OF ENZYMES THAT CATALYZE PYRUVATH SYNTHESIS FROM FORMIATE AND ACETYL COA, AND BACTERIES THAT EXPRESS THIS
|
UA121462C2
(uk)
|
2014-01-15 |
2020-06-10 |
Монсанто Текнолоджі Елелсі |
Спосіб та композиція для боротьби із бур'янами з використанням полінуклеотидів epsps
|
US20160340659A1
(en)
|
2014-01-30 |
2016-11-24 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. |
Actin binding peptides and compositions comprising same for inhibiting angiogenesis and treating medical conditions associated with same
|
US20170042893A1
(en)
|
2014-02-03 |
2017-02-16 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Use of casein kinase i inhibitors for depleting stem cells
|
WO2015118537A2
(fr)
|
2014-02-05 |
2015-08-13 |
Yeda Research And Development Co. Ltd. |
Micro-arn et compositions les comprenant pour le traitement et le diagnostic de troubles médicaux associés à la sérotonine, à l'adrénaline, à la noradrénaline, au glutamate et à l'hormone de libération de la corticotropine
|
ES2696348T3
(es)
|
2014-02-06 |
2019-01-15 |
Yeda Res & Dev |
Anticuerpos anti CD84, composiciones que comprenden los mismos y usos de los mismos
|
WO2015118547A1
(fr)
|
2014-02-10 |
2015-08-13 |
Protalix Ltd. |
Méthode de maintien de la stabilité d'une maladie chez un sujet atteint de la maladie de gaucher
|
US10564149B2
(en)
|
2014-02-11 |
2020-02-18 |
Brainstorm Cell Therapeutics Ltd. |
Populations of mesenchymal stem cells that secrete neurotrophic factors
|
US20170067894A1
(en)
|
2014-03-03 |
2017-03-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method and device for detection of pseudomonas aeruginosa
|
EP2923709A1
(fr)
|
2014-03-28 |
2015-09-30 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Vaccin contre la malaria multi-composants-multi-étapes
|
CN106413390B
(zh)
|
2014-04-01 |
2019-09-27 |
孟山都技术公司 |
用于控制虫害的组合物和方法
|
CA2945438C
(fr)
|
2014-04-10 |
2023-08-22 |
Bonus Therapeutics Ltd. |
Compositions pour la reparation des os
|
FI4026917T3
(fi)
|
2014-04-14 |
2024-02-14 |
Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd |
Menetelmä ja välineistö solujen tai kudoksen kuoleman tai DNA:n kudos- tai solualkuperäin määrittämiseksi DNA-metylaatioanalyysin avulla
|
ES2764504T3
(es)
|
2014-04-17 |
2020-06-03 |
Yeda Res & Dev |
Métodos y equipos para analizar restos de unión al ADN fijados al ADN
|
US11427647B2
(en)
|
2014-04-27 |
2022-08-30 |
Famewave Ltd. |
Polynucleotides encoding humanized antibodies against CEACAM1
|
AP2016009504A0
(en)
|
2014-04-27 |
2016-10-31 |
Ccam Biotherapeutics Ltd |
Humanized antibodies against ceacam1
|
ES2870658T3
(es)
|
2014-04-28 |
2021-10-27 |
Yeda Res & Dev |
Respuesta del microbioma a agentes
|
BR112016024555A2
(pt)
|
2014-05-04 |
2018-01-23 |
Forrest Innovations Ltd |
composições e métodos de utilização das mesmas para reduzir a resistência contra larvicidas para mosquitos
|
WO2015175957A1
(fr)
|
2014-05-16 |
2015-11-19 |
Baylor Research Institute |
Méthodes et compositions de traitement de maladies auto-immunes et inflammatoires
|
EP3145947A2
(fr)
|
2014-05-22 |
2017-03-29 |
Yeda Research and Development Co., Ltd. |
Micro-organismes recombinés pouvant fixer le carbone
|
WO2015186129A1
(fr)
|
2014-06-02 |
2015-12-10 |
Technion Research & Development Foundation Limited. |
Compositions et procédés d'inhibition sélective d'irp1 et traitement de l'inflammation
|
WO2015186128A1
(fr)
|
2014-06-02 |
2015-12-10 |
Kadimastem Ltd. |
Procédés d'induction de la myélinisation et de maturation des oligodendrocytes
|
WO2015200223A1
(fr)
|
2014-06-23 |
2015-12-30 |
Monsanto Technology Llc |
Compositions et méthodes de régulation de l'expression génétique par interférence par arn
|
US20170183376A1
(en)
|
2014-06-24 |
2017-06-29 |
Insight Biopharmaceuticals Ltd. |
Methods of purifying antibodies
|
EP3161138A4
(fr)
|
2014-06-25 |
2017-12-06 |
Monsanto Technology LLC |
Procédés et compositions pour administrer des acides nucléiques à des cellules végétales et réguler l'expression génique
|
EP3161480B1
(fr)
|
2014-06-25 |
2020-02-12 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Identification de cellules souches cancéreuses et utilisation de celles-ci pour des diagnostics et traitements
|
JP2017520549A
(ja)
|
2014-06-26 |
2017-07-27 |
ラモット アット テル アビブ ユニバーシティ, リミテッド |
核酸の送達のためのリポソーム製剤
|
WO2016005985A2
(fr)
|
2014-07-09 |
2016-01-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthode pour reprogrammer des cellules
|
RU2739952C2
(ru)
|
2014-07-15 |
2020-12-30 |
МЕДИММЬЮН, ЭлЭлСи |
Нейтрализующие антитела к вирусу гриппа b и пути их применения
|
JP6671363B2
(ja)
|
2014-07-15 |
2020-03-25 |
イッサム リサーチ ディヴェロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム リミティッド |
Cd44の単離されたポリペプチドおよびその使用
|
WO2016013008A1
(fr)
|
2014-07-21 |
2016-01-28 |
Novellusdx Ltd. |
Procédés et systèmes pour déterminer un indice oncogénique de mutations spécifiques d'un patient
|
WO2016013007A1
(fr)
|
2014-07-21 |
2016-01-28 |
Novellusdx Ltd. |
Procédés de détermination d'une réponse à un médicament de mutations spécifiques à un patient
|
CA2955842A1
(fr)
|
2014-07-29 |
2016-02-04 |
Monsanto Technology Llc |
Compositions et methodes pour lutter contre les insectes nuisibles
|
EP3194572B1
(fr)
|
2014-07-30 |
2023-10-25 |
Yeda Research and Development Co. Ltd. |
Milieux pour la culture de cellules souches pluripotentes
|
BR112017002884A2
(pt)
|
2014-08-14 |
2018-01-30 |
Memed Diagnostics Ltd |
?análise computacional de dados biológicos por meio do uso de variedade e hiperplano?
|
WO2016030899A1
(fr)
|
2014-08-28 |
2016-03-03 |
Yeda Research And Development Co. Ltd. |
Méthodes de traitement de la sclérose latérale amyotrophique
|
EP3191523B1
(fr)
|
2014-09-08 |
2019-08-07 |
Yeda Research and Development Co., Ltd. |
Compositions et procédés de traitement d'un cancer résistant à un inhibiteur de la tyrosine kinase (tki)
|
EP2992895A1
(fr)
|
2014-09-08 |
2016-03-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Vaccin contre la malaria multi-composants-multi-étapes
|
US10526416B2
(en)
|
2014-09-08 |
2020-01-07 |
Yeda Research And Development Co. Ltd. |
Anti-HER3 antibodies and uses of same
|
IL234638A0
(en)
|
2014-09-14 |
2014-12-02 |
Yeda Res & Dev |
NMDA receptor antagonists for the treatment of Gaucher disease
|
CN106999608A
(zh)
|
2014-09-21 |
2017-08-01 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
为了治疗脂质相关病症而下调mir‑132
|
US20170296650A1
(en)
|
2014-10-08 |
2017-10-19 |
Novartis Ag |
Combination of human cytomegalovirus neutralizing antibodies
|
AU2015336079C1
(en)
|
2014-10-20 |
2020-12-17 |
Gen-Probe Incorporated |
Red blood cell lysis solution
|
AU2015346969B2
(en)
|
2014-11-13 |
2019-03-21 |
Enzootic Holdings Ltd. |
Functional sex-reversal of decapod crustacean females
|
WO2016075546A2
(fr)
|
2014-11-14 |
2016-05-19 |
Antonio Lanzavecchia |
Anticorps qui neutralisent le virus ebola et leurs utilisations
|
CN107429291A
(zh)
|
2014-11-17 |
2017-12-01 |
耶达研究及发展有限公司 |
分析微生物组的方法
|
WO2016079736A2
(fr)
|
2014-11-17 |
2016-05-26 |
Yeda Research And Development Co. Ltd. |
Procédés de traitement de maladies associées à une fonction mitochondriale
|
ES2838679T3
(es)
|
2014-11-18 |
2021-07-02 |
Humabs Biomed S A |
Anticuerpos que neutralizan de forma potente el virus de la rabia y otros lisavirus y su utilización
|
WO2016079739A2
(fr)
|
2014-11-20 |
2016-05-26 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions et procédés de production de polypeptides présentant un schéma de glycosylation modifié dans des cellules végétales
|
EP3224353B9
(fr)
|
2014-11-26 |
2023-08-09 |
Technology Innovation Momentum Fund (Israel) Limited Partnership |
Élimination ciblée de gènes bactériens
|
EP3224363B1
(fr)
|
2014-11-27 |
2021-11-03 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Construction d'acide nucléique pour l'édition de génome
|
US10688330B2
(en)
|
2014-12-11 |
2020-06-23 |
Yeda Research And Development Co. Ltd. |
Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
WO2016103269A1
(fr)
|
2014-12-23 |
2016-06-30 |
Ramot At Tel-Aviv University Ltd. |
Populations de cellules progénitrices neuronales et leurs procédés de production et d'utilisation
|
DK3240892T5
(da)
|
2014-12-30 |
2020-10-19 |
Cell Cure Neurosciences Ltd |
Rpe-cellepopulationer og fremgangsmåder til dannelse deraf
|
CN114533761A
(zh)
|
2014-12-30 |
2022-05-27 |
细胞治疗神经科学有限公司 |
治疗视网膜疾病的方法
|
EP3240890B1
(fr)
|
2014-12-30 |
2021-06-16 |
Cell Cure Neurosciences Ltd. |
Évaluation de populations de cellules épithéliales pigmentaires rétiniennes
|
CN107406837A
(zh)
|
2015-01-04 |
2017-11-28 |
波塔力克斯有限公司 |
修饰的dna酶及其用途
|
WO2016116935A1
(fr)
|
2015-01-21 |
2016-07-28 |
Yeda Research And Development Co. Ltd. |
Utilisation de la rasa2 en tant que marqueur pronostique et thérapeutique pour un mélanome
|
EP3256589B1
(fr)
|
2015-01-22 |
2021-12-22 |
Monsanto Technology LLC |
Compositions et méthodes de lutte contre leptinotarsa
|
EP3261612A1
(fr)
|
2015-02-26 |
2018-01-03 |
Yeda Research and Development Co. Ltd |
Procédé favorisant la pousse des cheveux
|
WO2016142948A1
(fr)
|
2015-03-11 |
2016-09-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Oligonucléotides leurres pour le traitement de maladies
|
IL237852A0
(en)
|
2015-03-19 |
2016-03-24 |
Yeda Res & Dev |
Antibodies against amphigoline, medical preparations containing them and their use
|
EP3273971A4
(fr)
|
2015-03-27 |
2018-12-05 |
Yeda Research and Development Co. Ltd. |
Méthodes de traitement des maladies des motoneureones
|
CN107530427A
(zh)
|
2015-03-27 |
2018-01-02 |
南加利福尼亚大学 |
针对用于实体肿瘤的治疗的lhr的car t细胞疗法
|
WO2016157190A1
(fr)
|
2015-03-31 |
2016-10-06 |
Yeda Research And Development Co. Ltd. |
Glutamate oxaloacétate transaminase 1 (got1), préparations, procédés de génération des préparations et utilisations des préparations
|
US10960035B2
(en)
|
2015-04-01 |
2021-03-30 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Voleaui Center) |
Erodium crassifolium L'Her plant extracts and uses thereof
|
AU2016245434B2
(en)
|
2015-04-07 |
2020-10-29 |
Ela Pharma Ltd |
Compositions for treating and/or preventing cell or tissue necrosis specifically targeting Cathepsin C and/or CELA1 and/or CELA3A and/or structurally related enzymes thereto
|
EP3081575A1
(fr)
|
2015-04-12 |
2016-10-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Anticorps anti-plasmodium pour parasite
|
AU2016255725B2
(en)
|
2015-04-27 |
2021-09-23 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
|
US10674732B2
(en)
|
2015-04-29 |
2020-06-09 |
The State Of Israel, Ministry Of Agriculture & Rural Development Agricultural Research Organization |
Anti-phytopathogenic compositions
|
WO2016174652A1
(fr)
|
2015-04-30 |
2016-11-03 |
Technion Research & Development Foundation Limited |
Récepteurs antigéniques chimériques et méthodes d'utilisation correspondantes
|
CN108026566A
(zh)
|
2015-05-04 |
2018-05-11 |
特拉维夫大学拉莫特有限公司 |
用于使dna片段化的方法和试剂盒
|
US20180161300A1
(en)
|
2015-05-11 |
2018-06-14 |
Yeda Research And Development Co., Ltd. |
Citrin inhibitors for the treatment of cancer
|
WO2016185471A1
(fr)
|
2015-05-17 |
2016-11-24 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Compositions et méthodes de traitement du cancer
|
WO2016185457A1
(fr)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Méthodes pour favoriser la lymphagiogenèse
|
US10849985B2
(en)
|
2015-05-20 |
2020-12-01 |
Yeda Research And Development Co. Ltd. |
Method of targeting senescent cells
|
AU2016263293A1
(en)
|
2015-05-21 |
2017-12-14 |
Yeda Research And Development Co. Ltd. |
Bacterial populations for promoting health
|
AU2016273045B2
(en)
|
2015-05-29 |
2020-11-26 |
Opko Biologics Ltd. |
Pegylated oxyntomodulin variants
|
SI3303384T1
(sl)
|
2015-06-01 |
2021-11-30 |
Medimmune Llc |
Nevtralizirajoče vezavne molekule proti-influenci in njihova uporaba
|
CN107750125A
(zh)
|
2015-06-02 |
2018-03-02 |
孟山都技术有限公司 |
用于将多核苷酸递送至植物中的组合物和方法
|
EP3302030A4
(fr)
|
2015-06-03 |
2019-04-24 |
Monsanto Technology LLC |
Procédés et compositions pour l'introduction d'acides nucléiques dans des plantes
|
WO2016197064A1
(fr)
|
2015-06-04 |
2016-12-08 |
Epstein Alan L |
Immunothérapie des cellules car ciblées par lym-1 et lym-2
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
WO2016203477A1
(fr)
|
2015-06-18 |
2016-12-22 |
Yeda Research And Development Co. Ltd. |
Protocoles de conditionnement et utilisation de ceux-ci pour la régénération de tissu
|
WO2016203476A1
(fr)
|
2015-06-18 |
2016-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés et compositions pour le diagnostic et le traitement d'un cancer urothélial
|
WO2016203482A2
(fr)
|
2015-06-19 |
2016-12-22 |
Opko Biologics Ltd. |
Facteurs de coagulation à action prolongée et leurs procédés de production
|
WO2016207402A1
(fr)
|
2015-06-26 |
2016-12-29 |
Institute For Research In Biomedicine |
Protéines comprenant un fragment lair-1 muté et leurs utilisations
|
PL3322424T3
(pl)
|
2015-07-16 |
2024-03-04 |
Yeda Research And Development Co., Ltd. |
Zastosowanie centralnych limfocytów t pamięci przeciwko stronie trzeciej
|
MX2017016844A
(es)
|
2015-07-16 |
2018-08-15 |
Biokine Therapeutics Ltd |
Composiciones y procedimientos para tratar cancer.
|
US10668094B2
(en)
|
2015-07-19 |
2020-06-02 |
Yeda Research And Development Co. Ltd. |
Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure
|
KR102460440B1
(ko)
|
2015-07-22 |
2022-10-28 |
피토파마 인터내셔널 리미티드 |
꿀벌―섭취가능한 조성물, 이를 이용한 꿀 생산 방법 및 이에 의해 생산된 꿀
|
ES2865024T3
(es)
|
2015-07-29 |
2021-10-14 |
Hadasit Med Res Service |
Producción a gran escala de células de epitelio pigmentario retiniano
|
US20180221393A1
(en)
|
2015-08-03 |
2018-08-09 |
Biokine Therapeutics Ltd. |
Cxcr4 binding agents for treatment of diseases
|
WO2017021961A1
(fr)
|
2015-08-04 |
2017-02-09 |
Yeda Research And Development Co. Ltd. |
Procédés de criblage pour riborégulateurs et atténuateurs
|
EA201890424A1
(ru)
|
2015-08-05 |
2018-06-29 |
Селл Кьюр Нейросайансес Лтд. |
Получение клеток пигментного эпителия сетчатки
|
AU2016303631B2
(en)
|
2015-08-05 |
2022-07-28 |
Cell Cure Neurosciences Ltd. |
Preparation of photoreceptors for the treatment of retinal diseases
|
US10639350B2
(en)
|
2015-08-10 |
2020-05-05 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods and pharmaceutical compositions for improving wound healing using CD24
|
WO2017025967A1
(fr)
|
2015-08-13 |
2017-02-16 |
Forrest Innovations Ltd. |
Formulations et compositions d'administration d'acides nucléiques à des cellules végétales
|
WO2017033188A1
(fr)
|
2015-08-24 |
2017-03-02 |
Yeda Research And Development Co. Ltd. |
Huile et biocarburant d'origine algale et leurs procédés de production
|
US10765706B2
(en)
|
2015-09-03 |
2020-09-08 |
University Of South Florida |
Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
|
WO2017042816A1
(fr)
|
2015-09-10 |
2017-03-16 |
Yeda Research And Development Co. Ltd. |
Ablation de cellules dendritiques dont le test est positif pour la perforine, dans le traitement du cancer
|
WO2017059878A1
(fr)
|
2015-10-07 |
2017-04-13 |
Humabs Biomed Sa |
Anticorps neutralisant puissamment le virus de l'hépatite b et utilisations de ces derniers
|
WO2017072757A1
(fr)
|
2015-10-25 |
2017-05-04 |
Yeda Research And Development Co. Ltd. |
Anticorps ciblant la quiescine sulfhydryle oxydase (qsox1) et leurs utilisations
|
CA3002919A1
(fr)
|
2015-10-26 |
2017-05-04 |
Cell Cure Neurosciences Ltd. |
Preparation de cellules de l'epithelium pigmentaire retinien
|
CN109310648B
(zh)
|
2015-10-27 |
2022-06-03 |
杰伊制药公司 |
用于治疗癌症的包含大麻二酚和第二治疗剂的组合物
|
IL242380A0
(en)
|
2015-10-29 |
2016-02-01 |
Yeda Res & Dev |
A method for inducing the division of cardiomyocytes and treating heart diseases
|
WO2017077539A1
(fr)
|
2015-11-03 |
2017-05-11 |
Ariel-University Research And Development Company Ltd. |
Compositions destinées à la régénération et à la réparation de tissu nerveux
|
EP3374524A4
(fr)
|
2015-11-11 |
2019-06-26 |
Ramot at Tel-Aviv University Ltd. |
Procédés de détection de la 5-hydroxyméthylcytosine et diagnostic du cancer
|
US11679133B2
(en)
|
2015-11-30 |
2023-06-20 |
Kadimastem Ltd. |
Methods for differentiating and purifying pancreatic endocrine cells
|
EP3176183A1
(fr)
|
2015-12-02 |
2017-06-07 |
Yeda Research and Development Co. Ltd |
Compositions et procédés pour traiter un cancer non résistant à un inhibiteur de la tyrosine kinase (tki)
|
ES2924732T3
(es)
|
2015-12-16 |
2022-10-10 |
Univ Ramot |
Partículas que comprenden epiplón descelularizado
|
EP3397344A4
(fr)
|
2015-12-28 |
2019-08-28 |
B.G. Negev Technologies and Applications Ltd. at Ben-Gurion University |
Composition et méthode pour le traitement de la sclérose latérale amyotrophique
|
JP2019505511A
(ja)
|
2016-01-06 |
2019-02-28 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
悪性疾患、自己免疫疾患および炎症性疾患を処置するための組成物および方法
|
WO2017122203A1
(fr)
|
2016-01-11 |
2017-07-20 |
Technion Research & Development Foundation Limited |
Méthodes de détermination du pronostic de septicémie et traitement associé
|
EP3402513A4
(fr)
|
2016-01-13 |
2019-10-23 |
Medlmmune, LLC |
Méthode de traitement de la grippe a
|
WO2017125931A1
(fr)
|
2016-01-21 |
2017-07-27 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Plantes parthénocarpiques et procédés de production de celles-ci
|
IL243838A
(en)
|
2016-01-28 |
2017-07-31 |
Sp Nano Ltd |
The composition containing sp1 protein and carbon nanoparticles and its uses
|
IL243839B
(en)
|
2016-01-28 |
2018-01-31 |
Sp Nano Ltd |
Conductive wires
|
WO2017130205A1
(fr)
|
2016-01-31 |
2017-08-03 |
Hadasit Medical Research Services And Development Ltd. |
Populations de cellules souches pluripotentes ayant une composition de chromosomes sexuels non identiques et leurs utilisations
|
JP7072508B2
(ja)
|
2016-02-04 |
2022-05-20 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッド |
変異型p53と関連している疾患、障害または病状の処置におけるペプチドおよびその使用
|
ES2771223T3
(es)
|
2016-02-14 |
2020-07-06 |
Yeda Res & Dev |
Diagnóstico, predicción y tratamiento de la obesidad recidivante basados en el microbioma
|
WO2017138008A2
(fr)
|
2016-02-14 |
2017-08-17 |
Yeda Research And Development Co. Ltd. |
Procédés de modulation de l'exocytose de protéines et utilisations associées en thérapie
|
JP2019508422A
(ja)
|
2016-02-16 |
2019-03-28 |
イッスム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッドYissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
シアノバクテリアおよび植物の増殖を阻害するための非タンパク質性フェニルアラニン類似体
|
WO2017145162A1
(fr)
|
2016-02-23 |
2017-08-31 |
Chaya Brodie |
Production de cellules souches cancéreuses et leur utilisation
|
EP4043492A1
(fr)
|
2016-03-01 |
2022-08-17 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Anticorps spécifiques du récepteur humain du poliovirus (rvp)
|
EP3423589B1
(fr)
|
2016-03-03 |
2021-07-21 |
Memed Diagnostics Ltd. |
Analyse d'arn pour diagnostiquer un type d'infection
|
US20190216891A1
(en)
|
2016-03-06 |
2019-07-18 |
Yeda Research And Development Co., Ltd. |
Method for modulating myelination
|
IL244649A0
(en)
|
2016-03-17 |
2016-06-30 |
Yeda Res & Dev |
Methods for the isolation of barrel-like proteases and the identification of peptides that are cleaved by Alidan
|
US10421785B2
(en)
|
2016-04-11 |
2019-09-24 |
Bar-Ilan University |
Delta receptor agonist peptides and use thereof
|
EP3448998B1
(fr)
|
2016-04-27 |
2020-06-03 |
Gen-Probe Incorporated |
Réactif de lyse de cellules sanguines
|
CN109475581A
(zh)
|
2016-05-22 |
2019-03-15 |
耶达研究及发展有限公司 |
为了移植及诱导耐受性而使用肺细胞的方法
|
IL245861A0
(en)
|
2016-05-25 |
2016-09-04 |
Yeda Res & Dev |
Use of substances to treat drug-resistant tumors
|
US20190100732A1
(en)
|
2016-06-02 |
2019-04-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Assay for the removal of methyl-cytosine residues from dna
|
US11820833B2
(en)
|
2016-06-05 |
2023-11-21 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Peptides that inhibit binding of EPCR to its ligand to treat inflammation
|
WO2017212494A1
(fr)
|
2016-06-09 |
2017-12-14 |
Opko Biologics Ltd. |
Formulation d'oxyntomoduline à action prolongée, et procédés de production et procédés d'administration de cette dernière
|
CN109689894A
(zh)
|
2016-06-19 |
2019-04-26 |
耶路撒冷希伯来大学伊萨姆研发有限公司 |
在人单倍体细胞中筛选化学疗法抗性
|
MX2019000022A
(es)
|
2016-06-27 |
2019-09-18 |
Yeda Res & Dev |
Células veto generadas a partir de linfocitos t de memoria.
|
WO2018011796A1
(fr)
|
2016-07-10 |
2018-01-18 |
Memed Diagnostics Ltd. |
Diagnostic précoce d'infections
|
CN109661578B
(zh)
|
2016-07-10 |
2022-05-10 |
米密德诊断学有限公司 |
用于区分细菌和病毒感染的蛋白质特征
|
CA3030533A1
(fr)
|
2016-07-11 |
2018-01-18 |
Oren HERSHKOVITZ |
Facteur vii de coagulation a action prolongee et procedes de production associes
|
IL246722A0
(en)
|
2016-07-11 |
2016-09-29 |
Yeda Res & Dev |
Combined treatment to increase endogenous synthesis of nitric oxide
|
AU2017296175B2
(en)
|
2016-07-11 |
2023-11-02 |
Bonus Therapeutics Ltd. |
Cell compositions for tissue regeneration
|
IL291373B2
(en)
|
2016-07-11 |
2023-10-01 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Methods and systems for growing cells in culture
|
WO2018010789A1
(fr)
|
2016-07-13 |
2018-01-18 |
Humabs Biomed Sa |
Nouveaux anticorps se liant spécifiquement aux épitopes du virus zika et leurs utilisations
|
WO2018015881A1
(fr)
|
2016-07-18 |
2018-01-25 |
Ramot At Tel-Aviv University Ltd. |
Plate-forme modulaire pour thérapie ciblée
|
US20190203270A1
(en)
|
2016-07-24 |
2019-07-04 |
Yeda Research And Development Co., Ltd. |
Methods and kits for analyzing dna binding moieties attached to dna
|
WO2018029682A1
(fr)
|
2016-08-08 |
2018-02-15 |
Ramot At Tel-Aviv University Ltd. |
Systèmes bactériens servant à analyser des polypeptides ubiquitinylés
|
WO2018029690A1
(fr)
|
2016-08-10 |
2018-02-15 |
Memed Diagnostics Ltd. |
Système et procédé d'analyse de données biologiques
|
EP3497239A4
(fr)
|
2016-08-10 |
2020-02-26 |
Ramot at Tel-Aviv University Ltd. |
Analyse de l'état de méthylation et du nombre de copies
|
WO2018033911A1
(fr)
|
2016-08-14 |
2018-02-22 |
Ramot At Tel-Aviv University Ltd. |
Exosomes dérivés de cellules mésenchymateuses pour traiter des troubles neurologiques
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
WO2018037416A1
(fr)
|
2016-08-25 |
2018-03-01 |
Yeda Research And Development Co. Ltd. |
Procédés et compositions pour le traitement de maladies auto-immunes
|
EP3510047A1
(fr)
|
2016-09-07 |
2019-07-17 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Anticorps anti-nkp46 et leur utilisation thérapeutique
|
US11485971B2
(en)
|
2016-09-14 |
2022-11-01 |
Yeda Research And Development Co. Ltd. |
CRISP-seq, an integrated method for massively parallel single cell RNA-seq and CRISPR pooled screens
|
US11385241B2
(en)
|
2016-09-29 |
2022-07-12 |
Memed Diagnostics Ltd. |
Methods of prognosis and treatment
|
IL248468A0
(en)
|
2016-10-13 |
2017-01-31 |
Technion Res & Dev Foundation |
Use of caspase-3 inhibitors and caspase-3 activators in the preparation of medical preparations for cancer treatment and wound healing
|
IL248385A0
(en)
|
2016-10-18 |
2017-02-01 |
Yeda Res & Dev |
Treatment of circadian rhythm disorder
|
US10662226B2
(en)
|
2016-10-28 |
2020-05-26 |
The Regents of the University of Caiifomia |
Synthetic beta-amyloid peptides capable of forming stable antigenic oligomers
|
US20190359956A1
(en)
|
2016-11-10 |
2019-11-28 |
Yeda Research And Development Co. Ltd. |
Phosphotriesterases for treating or preventing organophosphate exposure associated damage
|
US11542508B2
(en)
|
2016-11-28 |
2023-01-03 |
Yeda Research And Development Co. Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for expressing an expression product of interest
|
WO2018100574A1
(fr)
|
2016-11-30 |
2018-06-07 |
Yeda Research And Development Co. Ltd. |
Méthodes de traitement de maladies et de la toxicité hépathique
|
BR112019003912A2
(pt)
|
2016-12-01 |
2019-05-28 |
Univ Ramot |
composição, método para criação de um hidrogel, matriz, hidrogel, método para indução da formação ou regeneração de um tecido neuronal, método para tratamento de uma lesão do nervo e método para prevenção ou tratamento de choque neurogênico após lesão do nervo
|
US11555178B2
(en)
|
2017-01-18 |
2023-01-17 |
Yeda Research And Development Co. Ltd. |
Genetically modified veto cells and use of same in immunotherapy
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
|
IL250916A0
(en)
|
2017-03-02 |
2017-06-29 |
Geiger Benjamin |
Methods for growing t cells in culture and their use
|
WO2018167780A1
(fr)
|
2017-03-12 |
2018-09-20 |
Yeda Research And Development Co. Ltd. |
Méthodes de diagnostic et de traitement du cancer
|
US20200150125A1
(en)
|
2017-03-12 |
2020-05-14 |
Yeda Research And Development Co., Ltd. |
Methods of diagnosing and prognosing cancer
|
KR20200031559A
(ko)
|
2017-03-16 |
2020-03-24 |
리니지 셀 테라퓨틱스, 인크. |
망막 질환 요법의 치료 효과를 측정하는 방법
|
WO2018185760A1
(fr)
|
2017-04-05 |
2018-10-11 |
Yeda Research And Development Co. Ltd. |
Système de culture ex-vivo et procédés d'utilisation de celui-ci
|
EP3612562A2
(fr)
|
2017-04-19 |
2020-02-26 |
Institute for Research in Biomedicine |
Nouveaux vaccins contre le paludisme et anticorps se liant aux sporozoïtes de plasmodium
|
IL252151A0
(en)
|
2017-05-07 |
2017-07-31 |
Fainzilber Michael |
Treatment of stress disorders
|
EP3621991A2
(fr)
|
2017-05-10 |
2020-03-18 |
Ariel Scientific Innovations Ltd. |
Procédés de purification d'anticorps
|
ES2939298T3
(es)
|
2017-05-21 |
2023-04-20 |
Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct |
Combinación de marcadores para el diagnóstico del cáncer
|
US20200172604A1
(en)
|
2017-05-23 |
2020-06-04 |
Technion Research & Development Foundation Limited |
Agents which inhibit gads dimerization and methods of use thereof
|
EP3630973A1
(fr)
|
2017-05-31 |
2020-04-08 |
Tropic Biosciences UK Limited |
Méthodes de sélection de cellules comprenant des événements d'édition de génome
|
GB201708665D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing extractability of solids from coffee beans
|
GB201708662D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing shelf-life of banana
|
WO2018229764A1
(fr)
|
2017-06-13 |
2018-12-20 |
Yeda Research And Development Co. Ltd. |
Traitement de la sclérose en plaques avancée ou progressive
|
US20200340057A1
(en)
|
2017-07-13 |
2020-10-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Dna targets as tissue-specific methylation markers
|
US20200165671A1
(en)
|
2017-07-13 |
2020-05-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Detecting tissue-specific dna
|
WO2019012544A1
(fr)
|
2017-07-13 |
2019-01-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Stratégie de pcr en gouttelettes à double sonde pour la détection spécifique de molécules d'adn circulantes spécifiques d'un tissu
|
IL253642A0
(en)
|
2017-07-24 |
2017-09-28 |
Seger Rony |
Combined treatment for cancer
|
IL253984A0
(en)
|
2017-08-14 |
2017-09-28 |
Yeda Res & Dev |
Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1
|
US11692166B2
(en)
|
2017-08-23 |
2023-07-04 |
Technion Research & Development Foundation Limited |
Compositions and methods for improving alcohol tolerance in yeast
|
WO2019042555A1
(fr)
|
2017-08-31 |
2019-03-07 |
Humabs Biomed Sa |
Anticorps multispécifiques se liant spécifiquement aux épitopes du virus zika et leurs utilisations
|
IL273460B1
(en)
|
2017-09-19 |
2024-03-01 |
Tropic Biosciences Uk Ltd |
Changing the specificity of plant non-coding RNA sequences to silence gene expression
|
CN111587123A
(zh)
|
2017-11-09 |
2020-08-25 |
品通治疗有限公司 |
用于生成和使用人源化构象特异性磷酸化的τ抗体的方法和组合物
|
IL255664A0
(en)
|
2017-11-14 |
2017-12-31 |
Shachar Idit |
Hematopoietic stem cells with enhanced properties
|
IL274979B1
(en)
|
2017-11-29 |
2024-03-01 |
Univ Ramot |
Methods for the prevention and treatment of neurogenic seizures
|
CN111615332A
(zh)
|
2017-11-29 |
2020-09-01 |
维德奥特有限公司 |
用于控制苋属杂草的组成物,套组及方法
|
EP3716993A1
(fr)
|
2017-12-03 |
2020-10-07 |
Yeda Research and Development Co. Ltd |
Traitement d'une maladie cardiaque ischémique
|
EP3723785A1
(fr)
|
2017-12-17 |
2020-10-21 |
Yeda Research and Development Co. Ltd |
Modulateurs du complexe signalosome cop9 (csn) et leurs utilisations
|
WO2019130313A1
(fr)
|
2017-12-28 |
2019-07-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé pour reproduire des rythmes circadiens sur une puce microfluidique
|
IL257225A
(en)
|
2018-01-29 |
2018-04-09 |
Yeda Res & Dev |
Treatment of sarcoma
|
IL257269A
(en)
|
2018-01-31 |
2018-04-09 |
Olender Tsviya |
Signaling is directed to the endoplasmic reticulum
|
WO2019155465A1
(fr)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Procédés d'identification et d'utilisation d'agents pour traiter des maladies associées à un dysfonctionnement de la barrière intestinale
|
EP3749689A1
(fr)
|
2018-02-08 |
2020-12-16 |
Yeda Research and Development Co. Ltd |
Inhibiteurs du protéasome 20s
|
EP3755340A4
(fr)
|
2018-02-23 |
2021-11-17 |
Carmel-Haifa University Economic Corporation Ltd. |
Méthodes de traitement d'un trouble de la mémoire et d'un dysfonctionnement cognitif
|
EP3759493A1
(fr)
|
2018-02-28 |
2021-01-06 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Méthodes de diagnostic et de traitement du cancer de la vessie
|
EP3765034A1
(fr)
|
2018-03-12 |
2021-01-20 |
Yeda Research and Development Co. Ltd |
Traitement d'une maladie cardiaque
|
US11413336B2
(en)
|
2018-03-23 |
2022-08-16 |
Board Of Regents, The University Of Texas System |
Coccidioides antigens and methods of their use
|
WO2019186569A1
(fr)
|
2018-03-29 |
2019-10-03 |
Yeda Research And Development Co. Ltd. |
Utilisation de gradients de champ électrique pour commander l'expression génique
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
KR20210005031A
(ko)
|
2018-03-29 |
2021-01-13 |
테크니온 리서치 엔드 디벨로프먼트 화운데이션 엘티디. |
Pten 억제제를 포함하는 소포 및 이의 용도
|
GB201807192D0
(en)
|
2018-05-01 |
2018-06-13 |
Tropic Biosciences Uk Ltd |
Compositions and methods for reducing caffeine content in coffee beans
|
WO2019220441A1
(fr)
|
2018-05-15 |
2019-11-21 |
Hadasit Medical Research Services And Development Ltd. |
Compositions et méthodes de traitement du cancer résistant à un agent anticancéreux
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neo-antigens
|
MX2020012534A
(es)
|
2018-05-27 |
2021-04-28 |
Biolinerx Ltd |
Agi-134 combinado con un inhibidor de punto de control para el tratamiento de tumores solidos.
|
WO2019234754A1
(fr)
|
2018-06-07 |
2019-12-12 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Constructions d'acide nucléique et procédés d'utilisation de celles-ci
|
CA3102975A1
(fr)
|
2018-06-07 |
2019-12-12 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Procedes de regeneration et de transformation de cannabis
|
EP3810636A1
(fr)
|
2018-06-25 |
2021-04-28 |
Yeda Research and Development Co. Ltd |
Systèmes et procédés permettant d'améliorer l'efficacité de l'édition génomique
|
EP3818075A1
(fr)
|
2018-07-04 |
2021-05-12 |
Ukko Inc. |
Procédés de ré-épitopage de protéines de blé et leur utilisation pour le traitement de maladie coeliaque
|
WO2020012467A2
(fr)
|
2018-07-08 |
2020-01-16 |
Yeda Research And Development Co. Ltd. |
Évaluation spécifique à une personne de la sensibilité aux probiotiques
|
BR112020024748A2
(pt)
|
2018-07-11 |
2021-03-23 |
Immunity Pharma Ltd. |
peptídeo isolado, e, composição farmacêutica
|
KR20210044220A
(ko)
|
2018-07-11 |
2021-04-22 |
카 메디컬 리미티드 |
SIRPalpha-4-1BBL 변이체 융합 단백질 및 이의 사용 방법
|
WO2020026241A1
(fr)
|
2018-07-31 |
2020-02-06 |
Collplant Ltd. |
Événement transgénique du tabac et procédés de détection et d'utilisation associés
|
IL261156A
(en)
|
2018-08-14 |
2020-02-27 |
Fass Deborah |
Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
|
WO2020041360A1
(fr)
|
2018-08-21 |
2020-02-27 |
Quidel Corporation |
Anticorps dbpa et leurs utilisations
|
JP2021535100A
(ja)
|
2018-08-24 |
2021-12-16 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
M2マクロファージ極性化を調節する方法及び治療におけるその使用
|
CN113038951B
(zh)
|
2018-09-20 |
2024-04-30 |
耶达研究及发展有限公司 |
治疗肌萎缩侧索硬化的方法
|
US20210338767A1
(en)
|
2018-09-25 |
2021-11-04 |
Biolinerx Ltd. |
Methods of selecting treatment for cxcr4-associated cancer
|
IL262658A
(en)
|
2018-10-28 |
2020-04-30 |
Memorial Sloan Kettering Cancer Center |
Prevention of age related clonal hematopoiesis and diseases associated therewith
|
IL263184A
(en)
|
2018-11-21 |
2020-05-31 |
Yarden Yosef |
Method of treating cancer and compositions for same
|
HRP20231440T1
(hr)
|
2018-12-19 |
2024-03-01 |
Humabs Biomed Sa |
Protutijela koja neutraliziraju virus hepatitisa b i njihova upotreba
|
WO2020152686A1
(fr)
|
2019-01-23 |
2020-07-30 |
Yeda Research And Development Co. Ltd. |
Milieux de culture pour cellules souches pluripotentes
|
IL264768A
(en)
|
2019-02-10 |
2020-08-31 |
Sagi Irit |
ANTI-MATRIX METALLOPROTEINASE 7 (MMP-7) inhibitory antibody and its use
|
IL264854A
(en)
|
2019-02-14 |
2020-08-31 |
Bahat Anat |
Spt5 inhibitors and methods of use thereof
|
WO2020170240A1
(fr)
|
2019-02-21 |
2020-08-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé de réduction d'une néphrotoxicité induite par des médicaments
|
WO2020170239A1
(fr)
|
2019-02-21 |
2020-08-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés de génération d'organoïdes pour criblage à haut rendement de médicaments
|
MX2021010611A
(es)
|
2019-03-05 |
2021-11-12 |
The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo |
Aves con genoma editado.
|
GB201903519D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
|
GB201903521D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
No title
|
GB201903520D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Bistable type ii opsins and uses thereof
|
KR20220004985A
(ko)
|
2019-03-27 |
2022-01-12 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
Cd40 활성화 특성을 가진 재조합 단백질
|
WO2020194317A1
(fr)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Méthode de traitement de troubles liés aux lipides
|
EP3946611A2
(fr)
|
2019-03-31 |
2022-02-09 |
Yeda Research and Development Co. Ltd |
Composés anti-viraux et anti-tumoraux
|
IL266433B
(en)
|
2019-05-02 |
2020-11-30 |
Sagi Irit |
Compositions comprising the propeptide of lysyl oxidase and uses thereof
|
WO2020230133A1
(fr)
|
2019-05-13 |
2020-11-19 |
Yeda Research And Development Co. Ltd. |
Biomarqueurs de micro-adn acellulaire pour le pronostic et le diagnostic de maladies neurodégénératives
|
IL266728B
(en)
|
2019-05-19 |
2020-11-30 |
Yeda Res & Dev |
Identification of recurrent mutant neopeptides
|
WO2020234888A1
(fr)
|
2019-05-22 |
2020-11-26 |
Hadasit Medical Research Services And Development Ltd. |
Procédés de culture de cellules pluripotentes humaines
|
CA3140406A1
(fr)
|
2019-05-28 |
2020-12-03 |
Shanghaitech University |
Composition et methodes pour le traitement d'une dysplasie ectodermique 2, type clouston
|
WO2020250232A1
(fr)
|
2019-06-12 |
2020-12-17 |
Hadasit Medical Research Services And Development Ltd. |
Procédés de génération d'oligodendrocytes
|
US20220307008A1
(en)
|
2019-06-16 |
2022-09-29 |
Yeda Research And Development Co. Ltd. |
Method for stabilizing intracellular rna
|
WO2020261281A1
(fr)
|
2019-06-27 |
2020-12-30 |
Ramot At Tel-Aviv University Ltd. |
Anticorps semaphorine 3a et leurs utilisations
|
KR20220042139A
(ko)
|
2019-07-04 |
2022-04-04 |
유코 아이엔씨. |
에피토프 제거된 알파 글리아딘 및 복강병 및 글루텐 민감성의 관리를 위한 이의 용도
|
KR20220044284A
(ko)
|
2019-07-11 |
2022-04-07 |
카 메디컬 리미티드 |
이종이량체 및 이의 사용방법
|
US20220281960A1
(en)
|
2019-07-16 |
2022-09-08 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for the treatment of tuberculosis
|
IL268111A
(en)
|
2019-07-16 |
2021-01-31 |
Fainzilber Michael |
Methods of treating pain
|
CA3147575A1
(fr)
|
2019-07-29 |
2021-02-04 |
Yeda Research And Development Co. Ltd. |
Procedes de traitement et de diagnostic du cancer du poumon
|
WO2021019536A1
(fr)
|
2019-07-30 |
2021-02-04 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Méthodes de régulation de la synthèse de cannabinoïdes chez la plante ou dans des cellules et plantes et cellules ainsi produites
|
EP4014046A1
(fr)
|
2019-08-12 |
2022-06-22 |
Yeda Research and Development Co. Ltd |
Test sanguin de réparation de l'adn pour prédire la réponse de patients atteints d'un cancer du poumon à une immunothérapie
|
US20240140988A1
(en)
|
2019-08-22 |
2024-05-02 |
Ariel Scientific Innovations Ltd. |
Scaled-up methods for purifying antibodies
|
WO2021038569A1
(fr)
|
2019-08-27 |
2021-03-04 |
Yeda Research And Development Co. Ltd. |
Traitement de la vaginose bactérienne
|
KR20220063188A
(ko)
|
2019-08-29 |
2022-05-17 |
비르 바이오테크놀로지, 인코포레이티드 |
B형 간염 바이러스 감염을 치료하기 위한 항체 조성물 및 방법
|
WO2021048852A1
(fr)
|
2019-09-11 |
2021-03-18 |
Yeda Research And Development Co. Ltd. |
Méthodes de traitement du cancer du sein
|
IL269674B
(en)
|
2019-09-25 |
2020-08-31 |
Roy Bar Ziv |
Assembling protein complexes on a chip
|
IL270306A
(en)
|
2019-10-30 |
2021-05-31 |
Yeda Res & Dev |
Prevention and treatment of pre-myeloid and myeloid malignancies
|
WO2021084526A1
(fr)
|
2019-10-31 |
2021-05-06 |
Yeda Research And Development Co. Ltd. |
Bactéries autotrophes génétiquement modifiées pour la conversion de co2 en matériaux organiques
|
CA3160506A1
(fr)
|
2019-11-11 |
2021-05-20 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Nanocorps de lutte contre les insectes et leurs utilisations
|
WO2021100034A1
(fr)
|
2019-11-19 |
2021-05-27 |
Protalix Ltd. |
Élimination de constructions à partir de cellules transformées
|
IL270800A
(en)
|
2019-11-20 |
2021-05-31 |
Yeda Res & Dev |
A method for treating Alzheimer's disease
|
US20230034677A1
(en)
|
2019-11-21 |
2023-02-02 |
INSERM (Institut National de la Santé et la Recherche (Médicale) |
Novel immunotherapies targeting pd-1 with anti-pd-1/il-15 immunocytokines
|
CN112898414B
(zh)
|
2019-12-04 |
2024-05-10 |
珠海泰诺麦博制药股份有限公司 |
抗人巨细胞病毒抗体及其用途
|
IL271656A
(en)
|
2019-12-22 |
2021-06-30 |
Yeda Res & Dev |
System and methods for identifying cells that have undergone genome editing
|
EP4077731A1
(fr)
|
2019-12-22 |
2022-10-26 |
Yeda Research and Development Co. Ltd |
Diagnostic de la démence frontotemporale
|
US20230048361A1
(en)
|
2019-12-31 |
2023-02-16 |
Kahr Medical Ltd. |
Methods of culturing t cells and uses of same
|
IL271778A
(en)
|
2019-12-31 |
2021-06-30 |
Ichilov Tech Ltd |
Methods for treating atopic dermatitis
|
US20230048719A1
(en)
|
2019-12-31 |
2023-02-16 |
Kahr Medical Ltd. |
Methods of culturing t cells with a 4-1bbl fusion polypeptide and uses of same
|
IL272074A
(en)
|
2020-01-15 |
2021-07-29 |
Immunity Pharma Ltd |
Peptide compounds and their use in methods of treating diseases
|
IL272194A
(en)
|
2020-01-22 |
2021-07-29 |
Yeda Res & Dev |
Multi-target antibodies for use in the treatment of diseases
|
WO2021152584A1
(fr)
|
2020-01-28 |
2021-08-05 |
Ariel Scientific Innovations Ltd. |
Procédés d'analyse de membranes cellulaires
|
WO2021152586A1
(fr)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Procédés d'analyse du microbiome, du profil d'immunoglobuline et de l'état physiologique
|
IL272389A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Kits containing antibodies to PD-L1 and their uses in therapy
|
IL272390A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Cancer treatment methods
|
WO2021152587A1
(fr)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Traitement d'une maladie hépatique aiguë à l'aide d'inhibiteurs de tlr-mik
|
CN115335532A
(zh)
|
2020-02-09 |
2022-11-11 |
Nlc制药有限公司 |
Sars-cov-2快速检测测试
|
IL272586A
(en)
|
2020-02-10 |
2021-08-31 |
Yeda Res & Dev |
A method for cell cluster analysis
|
EP4110823A1
(fr)
|
2020-02-26 |
2023-01-04 |
A2 Biotherapeutics, Inc. |
Polypeptides ciblant des complexes mage-a3 peptide-mhc et leurs méthodes d'utilisation
|
WO2021178637A1
(fr)
|
2020-03-05 |
2021-09-10 |
Iowa State University Research Foundation, Inc. |
Compositions immunogènes et vaccinales dirigées contre le sars-cov-2
|
EP4121441A1
(fr)
|
2020-03-16 |
2023-01-25 |
Yeda Research and Development Co. Ltd |
Analogues peptidiques et leur utilisation dans le traitement de maladies, troubles ou états associés à une protéine p53 mutante
|
KR20230003492A
(ko)
|
2020-03-29 |
2023-01-06 |
예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 |
고셔병 치료용 베타-글루코세레브로시다아제 변이체
|
CN115484836A
(zh)
|
2020-03-31 |
2022-12-16 |
百欧穆斯有限公司 |
用于预防和治疗烟雾诱发的肺部损伤的细菌
|
WO2021205444A1
(fr)
|
2020-04-06 |
2021-10-14 |
Yeda Research And Development Co. Ltd. |
Méthodes de diagnostic du cancer et de prédiction de la réactivité à une thérapie
|
WO2021205459A1
(fr)
|
2020-04-07 |
2021-10-14 |
Ramot At Tel-Aviv University Ltd. |
Compositions contenant du cannabidiol et leurs utilisations
|
US20230135456A1
(en)
|
2020-04-13 |
2023-05-04 |
Exoprother Medical Ltd. |
Cell-derived vesicles comprising wild-type p53 protein for antiviral therapy
|
US20210322483A1
(en)
|
2020-04-16 |
2021-10-21 |
Ichilov Tech Ltd. |
Cell-derived particles presenting heterologous cd24 and use thereof in therapy
|
WO2021229577A1
(fr)
|
2020-05-12 |
2021-11-18 |
Collplant Ltd. |
Collagène utilisé comme outil d'administration d'agents antiviraux à base de métaux
|
US20230183366A1
(en)
|
2020-05-13 |
2023-06-15 |
Inserm (Institut National De La Santé Et De La Recherch Médicale) |
Recombinant proteins with ox40 activating properties
|
IL274811B
(en)
|
2020-05-20 |
2021-05-31 |
Yeda Res & Dev |
Spatial information is developed for the analysis of individual cells
|
US20230293530A1
(en)
|
2020-06-24 |
2023-09-21 |
Yeda Research And Development Co. Ltd. |
Agents for sensitizing solid tumors to treatment
|
JP2023531520A
(ja)
|
2020-06-24 |
2023-07-24 |
ヴィア・バイオテクノロジー・インコーポレイテッド |
操作されたb型肝炎ウイルス中和抗体およびその使用
|
IL276599A
(en)
|
2020-08-09 |
2022-03-01 |
Yeda Res & Dev |
T cell receptor unique to mage-a1 and its uses
|
IL276627A
(en)
|
2020-08-10 |
2022-03-01 |
Yeda Res & Dev |
Compositions for diagnosis and treatment of coronavirus infections
|
US20230309480A1
(en)
|
2020-08-18 |
2023-10-05 |
International Rice Research Institute |
Methods of increasing outcrossing rates in gramineae
|
IL277488A
(en)
|
2020-09-21 |
2022-04-01 |
Yeda Res & Dev |
Weight regulation method
|
WO2022064494A2
(fr)
|
2020-09-23 |
2022-03-31 |
Yeda Research And Development Co. Ltd. |
Méthodes et compositions pour traiter des infections à coronavirus
|
IL277743A
(en)
|
2020-10-01 |
2022-04-01 |
Yeda Res & Dev |
A method for diagnosing breast cancer
|
US20230374447A1
(en)
|
2020-10-05 |
2023-11-23 |
Protalix Ltd. |
Dicer-like knock-out plant cells
|
US20230416707A1
(en)
|
2020-10-07 |
2023-12-28 |
Protalix Ltd. |
Long-acting dnase
|
EP4228637A1
(fr)
|
2020-10-15 |
2023-08-23 |
Yeda Research and Development Co. Ltd |
Méthode de traitement des cancers myéloïdes
|
IL278401A
(en)
|
2020-10-29 |
2022-05-01 |
Yeda Res & Dev |
Polynucleotides for editing RNA and a method for using them
|
IL302594A
(en)
|
2020-11-09 |
2023-07-01 |
1E Therapeutics Ltd |
Methods based on catalytic sequences for the treatment or prevention of bacterial infections
|
JP2023550979A
(ja)
|
2020-11-26 |
2023-12-06 |
ウッコ インコーポレイテッド |
改変された高分子量グルテニンサブユニット及びその使用
|
IL279559A
(en)
|
2020-12-17 |
2022-07-01 |
Yeda Res & Dev |
Controlling the ubiquitination process of mlkl for disease treatment
|
EP4267742A2
(fr)
|
2020-12-28 |
2023-11-01 |
1E Therapeutics, Ltd. |
Arnm de p21 ciblant des dnazymes
|
AU2021411103A1
(en)
|
2020-12-28 |
2023-07-13 |
1E Therapeutics, Ltd. |
P21 mrna target areas for silencing
|
AU2022206415A1
(en)
|
2021-01-10 |
2023-08-17 |
Supermeat The Essence Of Meat Ltd. |
Pluripotent stem cell aggregates and microtissues obtained therefrom for the cultured meat industry
|
US20240083843A1
(en)
|
2021-01-14 |
2024-03-14 |
Yeda Research And Development Co. Ltd. |
Methods of producing vitamin d
|
IL280340B
(en)
|
2021-01-21 |
2022-04-01 |
Yeda Res & Dev |
Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections
|
TW202245838A
(zh)
|
2021-01-26 |
2022-12-01 |
美商維爾生物科技股份有限公司 |
用於治療b型肝炎病毒感染的組成物及方法
|
IL305315A
(en)
|
2021-02-18 |
2023-10-01 |
Yeda res & development co ltd |
Methods for producing vaccines
|
EP4294429A1
(fr)
|
2021-02-18 |
2023-12-27 |
Yeda Research and Development Co. Ltd |
Bactéries génétiquement modifiées pour générer des vaccins
|
KR20230154994A
(ko)
|
2021-03-10 |
2023-11-09 |
마빌론 아게 |
Tdp-43에 대한 항체 및 이의 용도
|
IL281561A
(en)
|
2021-03-16 |
2022-10-01 |
Yeda Res & Dev |
Methods and devices for growing mouse embryos outside the uterus
|
AU2022247325A1
(en)
|
2021-03-30 |
2023-10-05 |
Biomx Ltd. |
Pseudomonas bacteriophage and uses thereof
|
IL282188A
(en)
|
2021-04-08 |
2022-11-01 |
Yeda Res & Dev |
Combined use of ketamine and bretigabine for the treatment of psychiatric disorders
|
AU2022272135A1
(en)
|
2021-05-12 |
2024-01-04 |
Biomx Ltd. |
Staphylococcus bacteriophage and uses thereof
|
IL283563A
(en)
|
2021-05-30 |
2022-12-01 |
Yeda Res & Dev |
Profiling of amps for the diagnosis, monitoring and treatment of microbiome-related diseases
|
WO2022259242A1
(fr)
|
2021-06-06 |
2022-12-15 |
Yeda Research And Development Co. Ltd. |
Traitement combiné du cancer
|
AU2022294310A1
(en)
|
2021-06-13 |
2024-05-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for reprogramming human cells
|
EP4355502A1
(fr)
|
2021-06-16 |
2024-04-24 |
Seedx Technologies Inc. |
Procédés de tri de graines de matthiola
|
NL2028466B1
(en)
|
2021-06-16 |
2022-12-21 |
Sakata Holland B V |
Methods of sorting matthiola seeds
|
CA3223344A1
(fr)
|
2021-07-02 |
2023-01-05 |
Tropic Biosciences UK Limited |
Retardement ou prevention du brunissement de bananes
|
WO2023003809A1
(fr)
|
2021-07-18 |
2023-01-26 |
Gamida-Cell Ltd. |
Populations de cellules nk thérapeutiques
|
WO2023002492A1
(fr)
|
2021-07-22 |
2023-01-26 |
Yeda Research And Development Co. Ltd. |
Optimisation de codon d'acides nucléiques
|
EP4380966A2
(fr)
|
2021-08-03 |
2024-06-12 |
Genicity Limited |
Complexe tcr modifié et ses procédés d'utilisation
|
EP4130028A1
(fr)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Complexe tcr modifié et leurs procédés d'utilisation
|
EP4384603A1
(fr)
|
2021-08-10 |
2024-06-19 |
Gamida-Cell Ltd. |
Cellules nk modifiées, leurs procédés de production et leurs utilisations
|
GB202112866D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to fusarium wilt in a banana
|
GB202112865D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to black sigatoka disease in banana
|
IL286430A
(en)
|
2021-09-14 |
2023-04-01 |
Yeda Res & Dev |
Multispecific antibodies for use in the treatment of diseases
|
CA3240113A1
(fr)
|
2021-12-08 |
2023-06-15 |
Yeda Research And Development Co. Ltd. |
Cellules progenitrices pulmonaires multipotentes pour la regeneration pulmonaire
|
WO2023144779A1
(fr)
|
2022-01-28 |
2023-08-03 |
Pfizer Inc. |
Variants d'antigène de coronavirus
|
WO2023209708A1
(fr)
|
2022-04-25 |
2023-11-02 |
Yeda Research And Development Co. Ltd. |
Compositions pour modifier la signalisation de messager secondaire de l'adp-ribose cyclique
|
WO2023242155A1
(fr)
|
2022-06-14 |
2023-12-21 |
Janssen Vaccines & Prevention B.V. |
Compositions et procédés pour le diagnostic d'une infection par le vih
|